Almost Family (AFAM) 10-K 14 Mar 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 30, 2016	Mar. 09, 2017	Jul. 01, 2016
Document and Entity Information
Entity Registrant Name	ALMOST FAMILY INC
Entity Central Index Key	799,231
Document Type	10-K
Document Period End Date	Dec. 30, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Public Float			$ 397,065,392
Entity Common Stock, Shares Outstanding		13,880,299
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
CONSOLIDATED STATEMENTS OF INCOME
Net service revenues	$ 623,541	$ 532,214	$ 495,829
Cost of service revenues (excluding depreciation & amortization)	335,472	281,842	263,994
Gross margin	288,069	250,372	231,835
General and administrative expenses:
Salaries and benefits	168,356	147,849	139,793
Other	72,939	66,000	62,071
Deal, transition and other costs	11,842	4,139	5,304
Total general and administrative expenses	253,137	217,988	207,168
Operating income	34,932	32,384	24,667
Interest expense, net	(5,776)	(2,287)	(1,632)
Income before income taxes	29,156	30,097	23,035
Income tax expense	(10,984)	(10,556)	(9,511)
Net income	18,172	19,541	13,524
Net loss attributable to noncontrolling interest	(519)	468	239
Net income attributable to Almost Family, Inc	$ 17,653	$ 20,009	$ 13,763
Per share amounts-basic:
Average shares outstanding (in shares)	10,153	9,505	9,333
Net income attributable to Almost Family, Inc. (in dollars per share)	$ 1.74	$ 2.11	$ 1.47
Per share amounts-diluted:
Average shares outstanding (in shares)	10,346	9,745	9,462
Net income attributable to Almost Family, Inc. (in dollars per share)	$ 1.71	$ 2.05	$ 1.45

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 30, 2016	Jan. 01, 2016
CURRENT ASSETS:
Cash and cash equivalents	$ 10,110	$ 7,522
Accounts receivable - net	99,212	92,270
Prepaid expenses and other current assets	11,432	9,672
TOTAL CURRENT ASSETS	120,754	109,464
PROPERTY AND EQUIPMENT - NET	10,732	10,000
GOODWILL	305,476	277,061
Transaction deposit	128,930
OTHER INTANGIBLE ASSETS	85,063	64,629
OTHER ASSETS	7,757	3,615
TOTAL ASSETS	658,712	464,769
CURRENT LIABILITIES:
Accounts payable	12,122	12,297
Accrued other liabilities	39,728	42,524
TOTAL CURRENT LIABILITIES	51,850	54,821
LONG-TERM LIABILITIES:
Revolving credit facility	262,456	113,790
Deferred tax liabilities	21,145	13,094
Sellers Notes	12,500	6,556
Other liabilities	6,581	2,608
TOTAL LONG-TERM LIABILITIES	302,682	136,048
TOTAL LIABILITIES	354,532	190,869
Redeemable Noncontrolling Interest, Carrying Amount
HEALTHCARE INNOVATIONS	2,256	3,639
STOCKHOLDERS' EQUITY:
Preferred stock, par value $0.05; authorized 2,000 shares; none issued or outstanding
Common stock, par value $0.10; authorized 25,000; 10,489 and 10,125 issued and outstanding	1,051	1,013
Treasury stock, at cost, 117 and 103 shares	(3,258)	(2,731)
Additional paid-in capital	141,233	127,253
Almost Family Inc., stockholders equity	302,789	270,991
Noncontrolling interest - nonredeemable	(865)	(730)
Retained earnings	163,763	145,456
TOTAL STOCKHOLDERS' EQUITY	301,924	270,261
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 658,712	$ 464,769

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Thousands	Dec. 30, 2016	Jan. 01, 2016
CONSOLIDATED BALANCE SHEETS
Preferred stock, par value (in dollars per share)	$ 0.05	$ 0.05
Preferred stock, authorized shares	2,000	2,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, authorized shares	25,000	25,000
Common stock, issued shares	10,504	10,125
Common stock, outstanding shares	10,504	10,125
Treasury stock, shares	117	103

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Non-controlling Interest Non-Redeemable	Total
Balance at Dec. 31, 2013	$ 950	$ (2,340)	$ 103,858	$ 111,789	$ (186)	$ 214,071
Balance (in shares) at Dec. 31, 2013	9,500	(92)
Increase (Decrease) in Stockholders' Equity
Stock award maturities, net of shares surrendered or withheld	$ 1	$ (52)	156			105
Stock award maturities, net of shares surrendered or withheld (in shares)	14	(2)
Share awards and related compensation	$ 6		1,808			1,814
Share awards and related compensation (in shares)	60
Tax loss from stock-based compensation			40			40
Noncontrolling interests - redeemable fair value accretion				(6)		(6)
Net loss noncontrolling interests - nonredeemable					(234)	(234)
Net income attributable to Almost Family, Inc				13,763		13,763
Balance at Dec. 31, 2014	$ 957	$ (2,392)	105,862	125,546	(420)	229,553
Balance (in shares) at Dec. 31, 2014	9,574	(94)
Balance at Dec. 31, 2013						3,639
Increase (Decrease) in Temporary Equity [Roll Forward]
Noncontrolling interests - redeemable fair value accretion						6
Net gain (loss) noncontrolling interests - redeemable						(6)
Balance at Dec. 31, 2014						3,639
Increase (Decrease) in Stockholders' Equity
Stock award maturities, net of shares surrendered or withheld	$ 1	$ (339)	128			(210)
Stock award maturities, net of shares surrendered or withheld (in shares)	10	(9)
Share awards and related compensation	$ 11		2,110			2,121
Share awards and related compensation (in shares)	100
Tax loss from stock-based compensation			215			215
Stock provided in acquisitions	$ 44		18,938			18,982
Stock provided in acquisitions (in shares)	441
Noncontrolling interests - redeemable fair value accretion				(99)		(99)
Net loss noncontrolling interests - nonredeemable					(310)	(310)
Net income attributable to Almost Family, Inc				20,009		20,009
Balance at Jan. 01, 2016	$ 1,013	$ (2,731)	127,253	145,456	(730)	$ 270,261
Balance (in shares) at Jan. 01, 2016	10,125	(103)				10,125
Increase (Decrease) in Temporary Equity [Roll Forward]
Noncontrolling interests - redeemable fair value accretion						$ 99
Net gain (loss) noncontrolling interests - redeemable						(99)
Balance at Jan. 01, 2016						3,639
Increase (Decrease) in Stockholders' Equity
Stock award maturities, net of shares surrendered or withheld		$ (527)	230			(297)
Stock award maturities, net of shares surrendered or withheld (in shares)	1	(14)
Share awards and related compensation	$ 10		2,750			2,760
Share awards and related compensation (in shares)	98
Tax loss from stock-based compensation			353			353
Stock provided in acquisitions	$ 28		10,647			10,675
Stock provided in acquisitions (in shares)	280
Noncontrolling interests - redeemable fair value accretion				654		654
Net loss noncontrolling interests - nonredeemable					(135)	(135)
Net income attributable to Almost Family, Inc				17,653		17,653
Balance at Dec. 30, 2016	$ 1,051	$ (3,258)	$ 141,233	$ 163,763	$ (865)	$ 301,924
Balance (in shares) at Dec. 30, 2016	10,504	(117)				10,504
Increase (Decrease) in Temporary Equity [Roll Forward]
Acquired noncontrolling interests						$ (1,383)
Noncontrolling interests - redeemable fair value accretion						(654)
Net gain (loss) noncontrolling interests - redeemable						654
Balance at Dec. 30, 2016						$ 2,256

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Cash flows of operating activities:
Net income	$ 18,172	$ 19,541	$ 13,524
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	4,445	3,927	3,913
Provision for uncollectible accounts	11,708	12,743	9,417
Stock-based compensation	2,760	2,121	1,814
Loan cost amortization	336	281	190
Deferred income taxes	8,725	3,914	5,500
Net cash provided by operating activities	46,146	42,527	34,358
Change in certain net assets and liabilities, net of the effects of acquisitions:
Accounts receivable	(18,701)	(17,393)	(25,613)
Prepaid expenses and other current assets	(377)	2,402	(647)
Other assets	(1,215)	(585)	165
Accounts payable and accrued expenses	(1,410)	(5,745)	(1,277)
Net cash provided by operating activities	24,443	21,206	6,986
Cash flows of investing activities:
Capital expenditures	(6,206)	(3,117)	(1,231)
Cost basis investment		(1,000)
Transaction deposit	(128,930)
Acquisitions, net of cash acquired	(31,486)	(82,578)	(969)
Net cash used in investing activities	(166,622)	(86,695)	(2,200)
Cash flows of financing activities:
Credit facility borrowings	389,328	233,425	66,632
Credit facility repayments	(240,662)	(166,082)	(76,185)
Debt issuance fees	(3,900)	(1,161)
Proceeds from stock option exercises	230	128	156
Purchase of common stock in connection with share awards	(527)	(338)	(52)
Tax impact of share awards	353	215	40
Payment of special dividend		(50)	(35)
Principal payments on notes payable and capital leases	(55)	(12)	(702)
Net cash provided by (used in) provided by financing activities	144,767	66,125	(10,146)
Net change in cash and cash equivalents	2,588	636	(5,360)
Cash and cash equivalents at beginning of period	7,522		12,246
Cash and cash equivalents at end of period	10,110	7,522	6,886
Supplemental disclosures of cash flow information:
Cash payment of interest, net of amounts capitalized	5,472	1,890	1,264
Cash payment of taxes	2,549	4,651	$ 1,953
Summary of non-cash investing and financing activities:
Acquisitions funded by notes payable	6,000	5,000
Acquisitions funded by stock	$ 10,675	$ 18,982

Summary of Accounting Policies

Summary of Accounting Policies	12 Months Ended
	Dec. 30, 2016
Accounting Policies
Accounting Policies	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Consolidation and Description of Business The consolidated financial statements include the accounts of Almost Family, Inc. (a Delaware corporation) and its wholly-owned subsidiaries (collectively “ Almost Family ” or the “Company”). The Company is a leading provider of cost efficient, high quality home healthcare care services and related innovations to drive savings for payors and improve patient outcomes and experience. On December 31, 2016, subsequent to our year-end, the Company acquired an 80% controlling interest in the entity holding the home health and hospice assets of Community Health Systems, Inc. (“CHS” and “CHS Home Health” or “CHS JV Transaction”). CHS Home Health, a provider of skilled home health and hospice services, currently operates 74 home health and 15 hospice branch locations in 22 states. With the completion of this transaction, Almost Family now operates 340 branches across 26 states. The purchase price of $128.0 million was funded through borrowings on the Company's Revolving Credit Facility and is included in Transaction Deposit in the Consolidated Balance Sheet at December 30, 2016. CHS retained the remaining 20%. On June 18, 2016, the Company acquired certain home health agency assets primarily in Wisconsin, but also in Connecticut and Kentucky (collectively, the “Wisconsin Acquisition”). On January 5, 2016, the Company acquired 100% of the equity of Long Term Solutions, Inc. (“LTS”) for a purchase price of $37 million. On January 5, 2016, the Company purchased the assets of a Medicare-certified home health agency owned by Bayonne Visiting Nurse Association (“Bayonne”) located in New Jersey. On November 5, 2015, the Company completed the acquisition of Black Stone Operations, LLC (“Black Stone”). Black Stone owned and operated personal care and skilled home health services in western Ohio. On August 29, 2015, the Company completed the acquisition of Bracor, Inc. (dba “WillCare”). WillCare owned and operated Visiting Nurse (“VN”) and Personal Care (“PC”) branch locations in New York (12), and Connecticut (1). On July 22, 2015, the Company acquired Ingenios Health (“Ingenios”). Ingenios is a leading provider of technology enabled in-house clinical assessments for Medicare Advantage, Managed Medicaid and Commercial Exchange lives in four states and Washington, D.C. On March 2, 2015, the Company acquired the stock of WillCare’s Ohio operations. On January 29, 2015, the Company acquired a noncontrolling interest in a development stage analytics and software company, NavHealth, Inc. (“NavHealth”). The acquisitions are more fully described in Note 11, “Acquisitions.” The Company’s consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”). All intercompany balances and transactions have been eliminated. Fiscal Year End Effective with the first quarter of 2015, the Company adopted a 52-53 week fiscal reporting calendar under which it will report its annual results going forward in four equal 13-week quarters. Every fifth year, one quarter will include 14 weeks and that year will include 53 weeks of operating results. All references herein for the years 2016, 2015 and 2014 represent the fiscal years ended December 30, 2016 and January 1, 2016, and the calendar year ended December 31, 2014, respectively. New Accounting Pronouncements In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-15, Statement of Cash Flows, Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). ASU 2016-15 clarifies how entities should classify certain cash receipts and cash payments on the statement of cash flows. It also clarifies how the predominance principle should be applied when cash receipts and cash payments have aspects of more than one class of cash flows. ASU 2016-15 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted. The Company is currently evaluating the impact ASU 2016-15 will have on its consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation ( “ ASU 2016-09”). ASU 2016-09 is intended to simplify several aspects of the accounting for share-based payments. The guidance will be effective for fiscal years beginning after December 15, 2016, including interim periods within that year. The Company is in the process of evaluating the impact of the adoption of this ASU. In February 2016, the FASB issued ASU 2016-02, Leases ( “ ASU 2016-02”). ASU 2016-02 requires lessees to recognize assets and liabilities on their balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their income statements over the lease term. It will also require disclosures designed to give financial statement users information regarding the amount, timing, and uncertainty of cash flows arising from leases. The guidance is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted for all entities. The Company is currently evaluating the impact ASU 2016-02 will have on its consolidated financial statements and associated disclosures. In April 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (“Subtopic 835-30”): Simplifying the Presentation of Debt Issuance Costs . In certain instances, Subtopic 835-30 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. Subtopic 835-30 is effective for annual and interim periods beginning after December 15, 2015. With the adoption of Subtopic 835-30, amortization of debt issuance costs of $281 and $190 were reclassified from amortization expense to interest expense for the years-ended January 1, 2016 and December 31, 2014, respectively, while interest expense for the fiscal year ended December 30, 2016 includes $336 of debt issue costs amortization. In April 2015, the FASB issued ASU No. 2015-05, Intangibles – Goodwill and Other – Internal-Use Software (“Subtopic 350-40”): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement . Subtopic 350-40 provides guidance that all software licenses included in cloud computing arrangement be accounted for consistent with other licenses of intangible assets. However, if a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract, the accounting for which did not change. Subtopic 350-40 is effective for annual and interim periods beginning after December 15, 2015. The adoption of ASU No. 2015-05 did not affect the Company’s financial position and results of operations. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Topic 606 affects virtually all aspects of an entity’s revenue recognition, including determining the measurement of revenue and the timing of when it is recognized for the transfer of goods or services to customers. Topic 606 is effective for annual reporting periods beginning after December 15, 2017. The Company is continuing to evaluating Topic 606, but does not initially foresee a material impact from the adoption of Topic 606 on its 2018 financial position and results of operations. Cash and Cash Equivalents The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. Uninsured deposits at December 30, 2016 and January 1, 2016 were approximately $7,845 and $4,681, respectively. These amounts have been deposited with national financial institutions. Property and Equipment Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives (generally two to ten years for medical and office equipment and three years for internally developed software). Leasehold improvements are depreciated over the terms of the respective leases (generally three to ten years). Such costs are periodically reviewed for recoverability when impairment indicators are present. Such indicators include, among other factors, operating losses, unused capacity, market value declines and technological obsolescence. Recorded values of asset groups of property, plant and equipment that are not expected to be recovered through undiscounted future net cash flows are written down to current fair value, which generally is determined from estimated discounted future net cash flows (assets held for use) or net realizable value (assets held for sale). Goodwill and Other Intangible Assets Goodwill and indefinite lived intangible assets acquired are stated at fair value at the date of acquisition. Subsequent to acquisition, the Company conducts annual reviews for impairment, or more frequently if circumstances indicate impairment may have occurred. The Company reviews goodwill for impairment based on its identified reporting units, which are the same as its reportable segments. The Company tests goodwill for impairment by comparing the carrying value to the estimated fair value of its reporting units, determined using a combination of the market approach (guideline company and similar transaction method) and income approach (discounted cash flow analysis). The Company annually tests its indefinite-lived intangible assets, principally trade names, certificates of need, provider numbers and licenses. Specifically trade names are tested using a “relief-from-royalty” valuation method compared to the carrying value. Significant assumptions inherent in the valuation methodologies for goodwill and other intangibles are employed and include, but are not limited to, such estimates as future projected business results, growth rates, legislated changes in payment rates, weighted-average cost of capital for a market participant, royalty and discount rates . The Company has completed its most recent annual impairment tests as of December 30, 2016 and determined that no impairment existed. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives, such as the cost of non-compete agreements for which their estimated useful life is usually 3 years, beginning after the earn-out period, if any. The following table summarizes the activity related to the Company’s goodwill and other intangible assets: Other Intangible Assets Certificates of Need and Trade Non-compete Customer Goodwill Licenses Names Agreements Relationships Total Balances at December 31, 2014 $ $ $ $ $ — $ Acquisitions — Amortization — — — Balances at January 1, 2016 — Acquisitions Amortization — — Balance at December 30, 2016 $ $ $ $ $ $ In conjunction with the LTS acquisition in the Company’s HCI segment, the Company identified finite-lived intangible assets including Customer Relationships and Non-compete Agreements. Future annual amortization for these assets should approximate amortization for 2016 above. See Note 11 for further discussion of acquisitions. The following table summarizes the Company’s goodwill and other intangible assets by segment: Other Intangible Assets Certificates of Need and Trade Non-compete Customer Goodwill Licenses Names Agreements Relationships Total Visiting Nurse $ $ $ $ $ — $ Personal Care — Healthcare Innovations — — — — — January 1, 2016 balance $ $ $ $ $ — $ Visiting Nurse $ — $ Personal Care — Healthcare Innovations — December 30, 2016 balance $ $ $ $ $ $ Capitalization Policies Maintenance, repairs and minor replacements are charged to expense as incurred. Major renovations and replacements are capitalized to appropriate property and equipment accounts. Upon sale or retirement of property, the cost and related accumulated depreciation are eliminated from the accounts and the related gain or loss is recognized in the consolidated statement of income. The Company capitalizes the cost of internally developed computer software for the Company’s own use. Software development costs of approximately $1,279, $788 and $327 were capitalized in the years ended December 30, 2016, January 1, 2016 and December 31, 2014, respectively. Insurance Programs The Company bears significant risk under its large-deductible workers’ compensation insurance program and its self-insured employee health program. Under the workers’ compensation insurance program, the Company bears risk up to $400 per incident, after which stop-loss coverage is maintained. The Company purchases stop-loss insurance for the employee health plan that places a specific limit, generally $300, on its exposure for any individual covered life. Malpractice and general patient liability claims for incidents which may give rise to litigation have been asserted against the Company by various claimants. The claims are in various stages of processing and some may ultimately be brought to trial. The Company currently carries professional and general liability insurance coverage (on a claims made basis) for this exposure with no deductible. The Company also carries D&O coverage (also on a claims made basis) for potential claims against the Company’s directors and officers, including securities actions, with deductibles ranging from $175 to $500 per claim. The Company records estimated liabilities for its insurance programs based on information provided by the third-party plan administrators, historical claims experience, the life cycle of claims, expected costs of claims incurred but not paid, and expected costs to settle unpaid claims. The Company monitors its estimated insurance-related liabilities and recoveries, if any, on a monthly basis and records amounts due under insurance policies in other current assets, while recording the estimated carrier liability in other current liabilities. As facts change, it may become necessary to make adjustments that could be material to the Company’s results of operations and financial condition. Accounting for Income Taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the Company’s book and tax bases of assets and liabilities and tax carry-forwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred taxes is recognized in the period in which the enactment dates change. Valuation allowances are established when necessary on a jurisdictional basis to reduce deferred tax assets to the amounts expected to be realized. Noncontrolling Interest Redeemable The Company acquired a controlling interest in Imperium in October of 2013 and currently owns 72.0%. The Company is party to a put and call arrangement with respect to the remaining 28.0% non-controlling interest in Imperium. The redemption value for both the put and the call arrangement is equal to fair value. Due to the existing put and call arrangements, the noncontrolling interest is considered to be redeemable and is recorded on the balance sheet as a redeemable noncontrolling interest outside of permanent equity. The redeemable noncontrolling interest is recognized at the higher of 1) the accumulated earnings associated with the noncontrolling interest or 2) the redemption value as of the balance sheet date. Seasonality The Company’s VN segment operations located in Florida (which generated approximately 26% of that segment’s revenues in the year ended December 30, 2016) normally experience higher admissions during the first quarter and lower admissions during the third quarter than in the other quarters due to seasonal population fluctuations. Net Service Revenues The Company is paid for its services primarily by federal and state third-party reimbursement programs, commercial insurance companies, and patients. Revenues are recorded at established rates in the period during which the services are rendered. Appropriate allowances to give recognition to third party payment arrangements are recorded when the services are rendered. Approximately 68% of the Company’s consolidated net service revenues are derived from the Medicare program. Net service revenues are recorded under the Medicare prospective payment program (PPS) based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) changes in the base episode payments established by the Medicare program; (b) adjustments to the base episode payments for case-mix and geographic wages; (c) a low utilization payment adjustment (LUPA) if the number of visits was fewer than five; (d) a partial payment if a patient is transferred to another provider or if a patient is received from another provider before completing the episode; (e) a payment adjustment based upon the level of therapy services required (thresholds set at 6, 14 and 20 visits); (f) an outlier payment if the patient’s care was unusually costly (capped at 10% of total reimbursement); (g) the number of episodes of care provided to a patient; and (h) a 2% reduction for sequestration. At the beginning of each Medicare episode the Company calculates an estimate of the amount of expected reimbursement based on the variables outlined above and recognizes Medicare revenue on an episode-by-episode basis during the course of each episode over its expected number of visits. Over the course of each episode, as changes in the variables become known, adjustments are calculated and recorded as needed to reflect changes in expectations for that episode from those established at the start of the 60 day period until its ultimate outcome at the end of the 60 day period is known. Substantially all remaining revenues are earned on a per visit, hour or unit basis (as opposed to episodic). For all services provided, the Company uses either payor-specific or patient-specific fee schedules for the recording of revenues at the amounts actually expected to be received. Laws and regulations governing the Medicare and Medicaid programs are extremely complex and subject to interpretation. It is common for issues to arise related to: 1) medical coding, particularly with respect to Medicare, 2) patient eligibility, particularly related to Medicaid, and 3) other reasons unrelated to credit risk, all of which may result in adjustments to recorded revenue amounts. The Company continuously evaluates the potential for revenue adjustments and when appropriate provides allowances for losses based upon the best available information. There is at least a reasonable possibility that recorded estimates could change by material amounts in the near term. Changes in estimates related to prior periods (increased) decreased revenues by approximately ($608), ($365), and ($320) in 2016, 2015 and 2014, respectively. Revenue and Receivable Concentrations The following table sets forth the percent of the Company’s revenues generated from Medicare, state Medicaid programs and other payors for the year ended: 2016 2015 2014 Medicare % % % Medicaid & other government programs: Ohio % % % Connecticut % % % New York % % — % Tennessee % % % Kentucky % % % Wisconsin % — % — % Florida % % % Others % % % Subtotal % % % All other payors % % % Total % % % Concentrations in the Company’s accounts receivable were as follows: 2016 2015 Amount Percent Amount Percent Medicare $ % $ % Medicaid & other government programs: Ohio % % Connecticut % % Tennessee % % Wisconsin % — — % Kentucky % % Florida % % New York % % Others % % Subtotal % % All other payors % % Subtotal % % Allowances Total $ $ The ability of payors to meet their obligations depends upon their financial stability, future legislation and regulatory actions. The Company does not believe there are any significant credit risks associated with receivables from Federal and state third-party reimbursement programs. The allowance for uncollectible accounts principally consists of management’s estimate of amounts that may prove uncollectible for coverage, eligibility and technical reasons. Payor Mix Concentrations and Related Aging of Accounts Receivable The approximate breakdown by payor classification as a percent of total accounts receivable, net of contractual allowances, if any, were as follows: 2016 Payor 0-90 91-180 181-365 >1 yr. Total Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % 2015 Payor 0-90 91-180 181-365 >1 yr. Total Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % Variations between years are largely attributable to acquisitions. Allowance for Uncollectible Accounts by Payor Mix and Related Aging The Company records an estimated allowance for uncollectible accounts by applying estimated bad debt percentages to its accounts receivable aging. The percentages to be applied by payor type are based on the Company’s historical collection and loss experience. The Company’s effective allowances for uncollectible accounts as a percent of accounts receivable were as follows: 2016 Payor 0-90 91-180 181-365 >1 yr. >2 yrs. Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % 2015 Payor 0-90 91-180 181-365 >1 yr. >2 yrs. Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % Variations between years are largely attributable to focused collection efforts for specific payors. The Company’s allowance for uncollectible accounts at December 30, 2016 and January 1, 2016 was approximately $21,302 and $17,514, respectively. Contingent Service Revenues The Company, through its Imperium acquisition, provides strategic health management services to ACOs that have been approved to participate in the Medicare Shared Savings Program (“MSSP”). In some cases, the Company also had ownership interests in ACOs beginning January 1, 2015. ACOs are entities that contract with CMS to serve the Medicare fee-for-service population with the goal of better care for individuals, improved health for populations and lower costs. ACOs share savings with CMS to the extent that the actual costs of serving assigned beneficiaries are below certain trended benchmarks of such beneficiaries and certain quality performance measures are achieved. The MSSP is relatively new and therefore has limited historical experience, which impacts the Company’s ability to accurately accumulate and interpret the data available for calculating an ACO’s shared savings, if any. MSSP payments are not recognized in revenue until persuasive evidence of an agreement exists, services have been rendered, the payment is fixed and determinable and collectability is insured, which is generally satisfied upon cash receipt. Under such agreements, the Company recognized $4.3 million and $1.4 million in MSSP payments for cash received during 2016 and 2015 related to savings generated for the program period ended December 31, 2015 and December 31, 2014, respectively, which is included in the Company’s Healthcare Innovations segment revenues. The Company has yet to recognize potential MSSP payments, if any, for savings generated for the December 31, 2016 program period. Weighted Average Shares Net income per share is presented as a unit of basic shares outstanding and diluted shares outstanding. Diluted shares outstanding is computed based on the weighted average number of common shares and common equivalent shares outstanding. Common equivalent shares result from dilutive stock options and unvested restricted shares. The following table is a reconciliation of basic to diluted shares used in the earnings per share calculation for the fiscal year ended: 2016 2015 2014 Basic weighted average outstanding shares Dilutive effect of outstanding compensation awards Diluted weighted average outstanding shares The assumed conversions to common stock of 76, 20, and 94 of the Company’s outstanding stock options and unmet performance shares were excluded from the diluted EPS computation in 2016, 2015, and 2014, respectively, because these items, on an individual basis, have an anti-dilutive effect on diluted EPS. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Stock-Based Compensation Stock options and restricted stock are granted under various stock compensation programs to employees and independent directors. The Company accounts for such grants in accordance with ASC Topic 718, Compensation — Stock Compensation and amortizes the fair value of awards, after estimated forfeiture, on a straight-line basis over the requisite service periods. Accounting for Leases The Company accounts for operating leases using the straight-line rents method, which amortizes contracted total rents due evenly over the lease term. Advertising Costs The Company expenses the costs of advertising, as incurred. Advertising expense was $403, $393 and $306 for 2016, 2015 and 2014, respectively.

ACCRUED LIABILITIES

ACCRUED LIABILITIES	12 Months Ended
	Dec. 30, 2016
ACCRUED LIABILITIES
ACCRUED LIABILITIES	NOTE 2 - ACCRUED LIABILITIES Accrued liabilities consist of the following as of fiscal year ended: 2016 2015 Wages and employee benefits $ $ Insurance accruals Accrued taxes Kentucky Medicaid cost report (receivable) payable Accrued professional fees and other $ $

PROPERTY AND EQUIPMENT, NET

PROPERTY AND EQUIPMENT, NET	12 Months Ended
	Dec. 30, 2016
PROPERTY AND EQUIPMENT, NET
PROPERTY AND EQUIPMENT, NET	NOTE 3 - PROPERTY AND EQUIPMENT, NET Property and equipment, net, consist of the following as of the fiscal year ended: 2016 2015 Leasehold improvements $ $ Medical equipment Computer equipment Internally developed software Office and other equipment Vehicles Less accumulated depreciation $ $ Depreciation and amortization expense related to property, plant and equipment is recorded in general and administrative expenses - other and was $3,768, $3,321 and $3,850 in 2016, 2015 and 2014, respectively.

Revolving Credit Facility

Revolving Credit Facility	12 Months Ended
	Dec. 30, 2016
Revolving Credit Facility
Revolving Credit Facility	NOTE 4 - REVOLVING CREDIT FACILITY On December 5, 2016, the Company entered into a new and expanded revolving credit facility with JPMorgan Chase Bank, N.A., as Administrative Agent, and certain other lenders (the “Facility”). The Facility provides a credit line of $225.0 million on and after December 5, 2016, and up to $350 million on and after the closing of the Company’s acquisition of 80% of the membership interests in the CHS JV Transaction. The Facility also includes an accordion feature providing that up to $150 million of additional borrowings may be available upon our further request and approval by a lender or lenders willing to extend such borrowings. Borrowings, other than letters of credit, under the Facility generally will bear interest at a varying rate equal to the London Interbank Offered Rate (“LIBOR”) plus a margin which varies from 1.50% to 2.75%, depending on our leverage ratio. The Facility is secured by substantially all our assets and the assets and stock of our subsidiaries. Our subsidiaries have also guaranteed the Facility. The Facility has a maturity date of December 3, 2021. Debt issuance costs of $4.7 million were capitalized with the Facility and will be amortized through December, 2021. Borrowings under the Facility are subject to various covenants, including a maximum leverage ratio for all calculation dates ending on or before December 31, 2017, of 4.0 times earnings before interest, taxes, depreciation and amortization, as adjusted (“EBITDA”) plus “Acquired EBITDA” from pro-forma acquisitions as defined. The maximum leverage ratio steps down, to a maximum leverage ratio of 3.75 times EBITDA plus Acquired EBITDA for calculation dates after December 31, 2017, and on or before June 30, 2018, and to a maximum leverage ratio of 3.5 times EBITDA plus Acquired EBITDA for calculation dates on and after September 30, 2018. Borrowings under the revolving credit facility may be used for general corporate purposes, including acquisitions. A portion of the proceeds were used to repay all the outstanding obligations of our prior credit agreement. Additionally, on December 30, 2016 the Company borrowed approximately $128.9 million from the Facility to finance the CHS Home Health transaction, which was classified as a Transaction Deposit and included in Revolving credit facility in the Consolidated Balance Sheets. As of December 30, 2016, the Company was in compliance with the various financial covenants. Application of the Facility’s borrowing formula as of December 30, 2016, would have permitted approximately $78.6 million to be used. We had irrevocable letters of credit totaling $14.7 million in connection with our self-insurance programs. On January 25, 2017, the Company sold 3,450 shares of common stock for net proceeds of $144.3 million, after deducting the estimated underwriting discounts and commissions and our offering expenses, which were used to repay obligations under the Facility. As a result, credit available under the Facility increased thereafter to approximately $204 million. See Note 13, “Subsequent Events” for further details. The effective interest rates on our borrowings were 3.6% and 3.5% for 2016 and 2015, respectively.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 30, 2016
Fair Value Measurements
Fair Value Measurements	NOTE 5 - FAIR VALUE MEASUREMENTS The Company’s financial instruments consist of cash, accounts receivable, payables and debt instruments. Due to their short-term nature, the book values of cash, accounts receivable and payables are considered representative of their respective fair values. The fair value of the Company’s debt instruments approximates their carrying values as substantially all of such debt instruments have rates which fluctuate with changes in market rates. As of December 30, 2016, the Company does not have any assets or liabilities carried at fair value that are measured on a recurring basis.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 30, 2016
Income Taxes
Income Taxes	NOTE 6 - INCOME TAXES The provision for income taxes consists of the following as of the fiscal year ended: 2016 2015 2014 Federal - current $ $ $ State and local - current Deferred $ $ $ A reconciliation of the statutory to the effective rate of the Company is as follows as of the fiscal year ended: 2016 2015 2014 Tax provision using statutory rate % % % State and local taxes, net of Federal benefit % % % Valuation allowance % % % Noncontrolling interest related % % % Permanent differences % % % Legal settlement related — % % — % Tax provision for continuing operations % % % The Company has provided a valuation allowance against certain net deferred tax assets based upon management’s estimation of realizability of those assets through future taxable income. This valuation allowance was based in large part on the Company’s history of generating operating income or losses in individual tax locales and expectations for the future. The Company’s ability to generate the expected amounts of taxable income from future operations to realize its recorded net deferred tax assets is dependent upon general economic conditions, competitive pressures on revenues and margins and legislation and regulation at all levels of government. There can be no assurances that the Company will meet its expectations of future taxable income. However, management has considered the above factors in reaching its conclusion that it is more likely than not that future taxable income will be sufficient to realize the deferred tax assets (net of valuation allowance) as of December 30, 2016. During 2016, the valuation allowance increased by $0.7 million due to a change in expected realizability of deferred tax assets. The principal tax carry-forwards and temporary differences were as follows as of the fiscal year ended: 2016 2015 Deferred tax assets Non-deductible reserves and allowances $ $ Insurance accruals Net operating loss carryforwards Valuation allowance Total deferred tax assets Deferred tax liabilities Goodwill & intangibles Accelerated depreciation Total deferred tax liabilities Net deferred tax liabilities $ $ Total net deferred tax liabilities are reflected in the accompanying balance sheet as long-term liabilities. The Company had book goodwill of $105.1 million and $113.2 million at December 30, 2016 and January 1, 2016, respectively, which was not deductible for tax purposes. As of December 30, 2016, the Company has U.S. operating loss carry forwards of $8.1 million that are available to reduce future taxable income. If not used to offset taxable income, the losses will expire between 2028 and 2034. Due to U.S. limitations on acquired operating losses, a valuation allowance has been established on $0.8 million of these losses. State operating loss carryforwards totaling $42.9 million at December 30, 2016 are being carried forward in jurisdictions where the Company is permitted to use tax losses from prior periods to reduce future taxable income. If not used to offset future taxable income, these losses will expire between 2017 and 2036. Due to uncertainty regarding the Company’s ability to use some of the carryforwards, a valuation allowance has been established on $35.8 million of state net operating loss carryforwards. Based on the Company’s historical record of producing taxable income and expectations for the future, the Company has concluded that future operating income will be sufficient to give rise to taxable income sufficient to utilize the remaining state net operating loss carryforwards. US GAAP prescribes a recognition threshold and measurement attribute for the accounting and financial statement disclosure of tax positions taken or expected to be taken in a tax return. The evaluation of a tax position is a two-step process. The first step requires the Company to determine whether it is more likely than not that a tax position will be sustained upon examination based on the technical merits of the position. The second step requires the Company to recognize in the financial statements each tax position that meets the more likely than not criteria, measured at the amount of benefit that has a greater than 50% likelihood of being realized. The Company’s unrecognized tax benefits would affect the tax rate, if recognized. The Company includes the full amount of unrecognized tax benefits in other noncurrent liabilities in the consolidated balance sheets. The Company anticipates it is reasonably possible an increase or decrease in the amount of unrecognized tax benefits could be made in the next twelve months. However, the Company does not presently anticipate that any increase or decrease in unrecognized tax benefits will be material to the consolidated financial statements. Changes in unrecognized tax benefits were as follows. 2016 2015 2014 Beginning of fiscal year $ $ $ — Increases related to positions taken on items from prior years — — — Decreases related to positions taken on items from prior years — — Increases related to positions taken in the current year Lapse of statute of limitations — — — Settlement of uncertain tax positions with tax authorities — — — Balance at end of fiscal year $ $ $ For federal tax purposes, the Company is currently subject to examinations for tax years after 2012, while for state purposes, tax years after 2010 are subject to examination, depending on the specific state rules and regulations. The Internal Revenue Service completed an examination of the Company’s December 31, 2011 tax year as well as an examination of Omni Home Health Holdings, Inc.’s federal tax returns for the year ended December 31, 2012 and the period ended December 6, 2013. The Company may from time to time be assessed interest and penalties by major tax jurisdictions, although any such assessments historically have been minimal and immaterial to its financial results. Assessments for interest and/or penalties are classified in the Consolidated Statement of Income as General and administrative - other.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 30, 2016
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY	NOTE 7 - STOCKHOLDERS’ EQUITY Employee Stock Incentive Plans The Company has a 2000 Employee Stock Option Plan which initially provided for options to purchase up to 1,000 shares of the Company’s common stock to key employees, officers and directors. The Board of Directors determines the amount and terms of the options, which cannot exceed ten years. At December 30, 2016, options for 83 shares were outstanding under this plan. There are no shares available for future grant. The 2007 Stock and Incentive Compensation Plan provided for stock awards up to 500 shares of the Company’s common stock to employees, non-employee directors or independent contractors, with a maximum number of full value restricted share awards up to 200. As of December 30, 2016, options for 230 shares were outstanding under this plan, while 162 restricted shares had been awarded. There are no shares available for future grant. The 2013 Stock and Incentive Compensation Plan provides for stock awards up to 700 shares of the Company’s common stock to employees, non-employee directors or independent contractors. As of December 30, 2016, options awarded and outstanding under this plan were 190 and 188, respectively, and restricted shares awarded and outstanding were 296 and 213, respectively. There are 214 shares available for future grant. Historically, the Company has issued restricted share and/or option awards to employees and non-employee directors. The Board of Directors determines the amount and terms of the options, which cannot exceed ten years. Under both the 2013 and 2007 Stock and Incentive Compensation Plans, restricted share awards cliff vest on the third anniversary, while option share awards vest annually in 25% increments over four years. On March 4, 2016, the Company granted 56 performance-based, restricted share awards (“performance shares”) under the 2013 Stock and Incentive Compensation Plans to key executives. These performance shares entitle certain executives to receive a number of shares of our common stock based upon the Company’s satisfaction of certain performance criteria approved by the Board of Directors. The awards cliff-vest at the end of three years and were valued at the market price of a share of the Company’s stock on the date of grant assuming 100% achievement. Under the plan, achievement ranges from 0% to 200%. The Company deemed achievement not probable at December 30, 2016 and recorded no compensation expense. Changes in award shares outstanding are summarized as follows: Performance shares Restricted shares Options Wtd. Avg. Wtd. Avg. Wtd. Avg. Shares Grant Price Shares Grant Price Shares Ex. Price January 1, 2016 — — Granted Vested or Exercised — — Forfeited December 30, 2016 $ $ $ Aggregate intrinsic value represents the estimated value of the Company’s common stock at end of the period in excess of the weighted average exercise price multiplied by the number of options outstanding or exercisable. The aggregate intrinsic value of options outstanding and exercisable at December 30, 2016 is $8,221 and $6,403, respectively. The total intrinsic value of stock options exercised during 2016, 2015 and 2014 was $442, $171 and $460, respectively. The following table summarizes information about stock options at December 30, 2016: Options Outstanding Options Exercisable Wtd. Avg. Wtd. Avg. Range of Remaining Wtd. Avg. Remaining Wtd. Avg. Exercise Contractual Exercise Contractual Exercise Price Shares Life Price Shares Life Price $0.00-20.00 $ $ $20.01-30.00 $ $ Over $30.00 $ $ $ $ The following table details exercisable options and related information for year end: 2016 2015 2014 Exercisable at end of year Weighted average price $ $ $ Weighted average fair value of options granted during the year $ $ $ The following table details unvested option activity for the year ended December 30, 2016: Wtd. Avg. Shares Ex. Price January 1, 2016 $ Vested Granted Forfeited December 30, 2016 $ The fair value of each option award is estimated on the date of grant using the Monte Carlo option valuation model with suboptimal exercise behavior. The Monte Carlo model places greater emphasis on market evidence and predicts more realistic results because it considers open form information including volatility, employee exercise behaviors and turnover. Stock options have a contractual term of 10 years. The following assumptions were used in determining the fair value of option awards for 2016, 2015 and 2014: Equivalent Expected Implied Grant date interest rate volatility expected lives March 4, 2016 % % March 2, 2015 % % March 17, 2014 % % Expected volatility is based on an analysis that looks at the unbiased standard deviation of the Company’s common stock over the option term. The expected life of the options represents the period of time that the Company expects the options granted to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option for the expected term of the instrument. A 0% dividend yield was assumed as no dividend payout over the term of the award is expected. As of December 30, 2016, there was $5,596 of total unrecognized compensation cost, including performance restricted shares at 100% of target, after estimated forfeitures, related to unvested share-based compensation granted under the plans. That cost is expected to be recognized over a weighted-average period of 2.28 years. The total fair value of option shares vested during 2016 and 2015 was $697 and $487, respectively. Employee Stock Purchase Plan The Company has an Employee Stock Purchase Plan (“2009 ESPP”) which, if implemented, could provide employees of the Company and its subsidiaries with an opportunity to participate in the growth of the Company and to further align the interest of the employees with the interests of the Company through the purchase of shares of the Company’s Common Stock. Under the 2009 ESPP, 300 shares of the Company’s Common Stock have been authorized for issuance. As of December 30, 2016, all 300 shares remain available for issuance.

RETIREMENT PLAN

RETIREMENT PLAN	12 Months Ended
	Dec. 30, 2016
RETIREMENT PLAN
RETIREMENT PLAN	NOTE 8 - RETIREMENT PLAN The Company administers a 401(k) defined contribution retirement plan for the benefit of the majority of its employees. Employees may participate in the plan immediately upon employment. The Company matches contributions in an amount equal to one-quarter of the first 5% of each participant’s contribution to the plan after completion of one year of service with the Company. 401(k) assets are held by an independent trustee, are not assets of the Company, and accordingly are not reflected in the Company’s balance sheets. The Company’s retirement plan expense was approximately $1,054, $1,080 and $910 in 2016, 2015 and 2014, respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 30, 2016
Commitments and Contingencies
Commitments and Contingencies	NOTE 9 - COMMITMENTS AND CONTINGENCIES Operating Leases The Company leases certain real estate, office space, and equipment under non-cancelable operating leases expiring at various dates through 2025 and which contain various renewal and escalation clauses. Rent expense amounted to approximately $13,969, $11,356 and $12,846 for 2016, 2015 and 2014, respectively. At December 30, 2016, minimum rental payments under these leases were as follows: 2017 $ 2018 2019 2020 2021 Thereafter Total $ Legal Proceedings From time to time, the Company is subject to various legal actions arising in the ordinary course of the Company’s business, including claims for damages for personal injuries. In the Company’s opinion, after discussion with legal counsel, the ultimate resolution of any of these pending ordinary course claims and legal proceedings will not have a material effect on the Company’s financial position or results of operations. The Company has complied with a civil subpoena from the United States Department of Justice received in January of 2016 related to two locations acquired along with SunCrest in late 2013. SunCrest had previously acquired the locations in its merger with Omni Home Health in 2011. The subpoena seeks the production of various pre-acquisition business records limited to certain Omni operations in Sarasota and Tampa, Florida for the years 2007-2011. The Company is cooperating fully with this investigation. The subject operations generated less than 1% of the Company’s consolidated revenues.

Segment Data

Segment Data	12 Months Ended
	Dec. 30, 2016
Segment Data
Segment Data	NOTE 10 - SEGMENT DATA At December 30, 2016, the Company has two divisions, Home Health care and Healthcare Innovations. The Home Health care division is comprised of two reportable segments, Visiting Nurses Services (“VN” or “Visiting Nurse”) and Personal Care Services (“PC” or “Personal Care”). Healthcare Innovations is also a reportable segment. Consistent with information given to the chief operating decision maker, the Company does not allocate certain corporate expenses to the reportable segments. These expenses are included in Unallocated below. The Company evaluates the performance of its business segments based on operating income. Intercompany and intersegment transactions have been eliminated. Segment information within the consolidated financial statements have been recast for all periods presented to conform with the new segment reporting structure. The Company’s VN segment provides skilled medical services in patients’ homes largely to enable recipients to reduce or avoid periods of hospitalization and/or nursing home care. VN Medicare revenues are generated on a per episode basis rather than a fee per visit or day of care. Approximately 95% of the VN segment revenues are generated from the Medicare program, while the balance is generated from Medicaid and private insurance programs. The Company’s PC segment services are also provided in patients’ homes. These services (generally provided by paraprofessional staff such as home health aides) are generally of a custodial rather than skilled nature. PC revenues are generated on an hourly basis. Approximately 83% of the PC segment revenues are generated from Medicaid and other government programs, while the balance is generated from insurance programs and private pay patients. The Company’s Healthcare Innovations business segment was created to house and separately report on our developmental activities outside the traditional home health business platform. These activities are intended ultimately, whether directly or indirectly, to benefit the Company’s patients and payers through the enhanced provision of home health services. The activities all share a common goal of improving patient experiences and quality outcomes while lowering costs. They include, but are not limited to, items such as: technology, information, population health management, risk-sharing, care coordination and transitions, clinical advancements, enhanced patient engagement and informed clinical decision. 2016 2015 2014 Net service revenues Home Health Visiting Nurse $ $ $ Personal Care Healthcare Innovations $ $ $ Operating income (loss) Home Health Visiting Nurse $ $ $ Personal Care Healthcare Innovations Unallocated $ $ $ Identifiable assets Home Health Visiting Nurse $ $ Personal Care Healthcare Innovations Unallocated $ $ Identifiable liabilities Home Health Visiting Nurse $ $ Personal Care Healthcare Innovations Unallocated $ $ Noncontrolling Interest - Redeemable Healthcare Innovations $ $ Capital expenditures Home Health Visiting Nurse $ $ $ Personal Care Healthcare Innovations — Unallocated $ $ $ Depreciation and amortization Home Health Visiting Nurse $ $ $ Personal Care Healthcare Innovations — Unallocated $ $ $

Acquisitions

Acquisitions	12 Months Ended
	Dec. 30, 2016
Acquisitions
Acquisitions	NOTE 11 - ACQUISITIONS The Company completed each of the following acquisitions in pursuit of its strategy for operational expansion in the eastern United States through an expanded service base and enhanced position in certain geographic areas. The purchase price of each acquisition was determined based on the Company’s analysis of comparable acquisitions, expected cash flows and arm’s length negotiation with the sellers. Each acquisition was included in the Company’s consolidated financial statements from the respective acquisition date. Goodwill recognized from the acquisitions primarily relates to expected contributions of each entity to the overall corporate strategy in addition to synergies and acquired workforce, which are not separable from goodwill. Goodwill and other intangible assets generated in asset purchase transactions are expected to be amortizable for tax purposes on a straight-line basis over 15 years, unless otherwise noted. Goodwill and other intangible assets generated in stock purchase transactions are not amortizable, unless otherwise noted. During the third quarter of 2016, one of the Company’s HCI subsidiaries redeemed certain outstanding shares increasing the Company's ownership percentage to 72.0% from 61.5%. On June 18, 2016, the Company acquired certain home health agency assets primarily in Wisconsin, but also in Connecticut and Kentucky (collectively, the Wisconsin acquisition). The purchase price was $6.1 million, funded through borrowings on the Company’s bank credit facility. The post-acquisition operating results of these agencies are primarily reported in the Company’s PC segment. No accounts receivable were acquired. Thus, accounts receivable need to accumulate to normal levels post close. On January 5, 2016, the Company acquired 100% of the equity of LTS. LTS is a provider of in-home nursing assessments for the long-term care insurance industry. LTS provides assessments in all 50 U.S. states and a number of foreign countries. The purchase price of $37 million was funded through borrowings on the Company’s bank credit facility, seller notes and issuance of the Company’s common stock. The Company expects goodwill from this transaction to be deductible for tax purposes. Approximately 74.4% of LTS’s 2016 revenue was from two customers. LTS’s post acquisition operating results are reported in our Healthcare Innovations business segment. On January 5, 2016, the Company purchased the assets of a Medicare-certified home health agency owned by Bayonne located in New Jersey. Bayonne’s post acquisition operating results are reported in our VN segment. On November 5, 2015, the Company acquired the stock of Black Stone Operations, LLC (“Black Stone”). Black Stone is a provider of in-home personal care and skilled home health services in western Ohio and operates under the name “Home Care by Black Stone”. The purchase price of $40 million was funded through borrowings on the Company’s bank credit facility, seller notes and issuance of the Company’s common stock. The Company expects goodwill from this transaction to be deductible for tax purposes. Black Stone’s post acquisition operating results are reported in the Company’s VN and PC segments and Healthcare Innovations segment. On August 29, 2015, the Company acquired 100% of the equity of Bracor, Inc. (dba “WillCare”). WillCare, based in Buffalo, NY, owned and operated VN and PC branch locations in New York (12) and Connecticut (1). The purchase price was approximately $50.8 million. The transaction was funded by borrowings under the Company’s bank credit facility. WillCare’s post acquisition operating results are reported in the Company’s VN and PC segments. On July 22, 2015, the Company acquired 100% of the equity of Ingenios Health Co. for approximately $11.4 million of the Company’s common stock plus $2 million in cash. Ingenios is a leading provider of technology enabled in-home clinical assessments for Medicare Advantage, Managed Medicaid and Commercial Exchange lives in four states and Washington, D.C. The post-acquisition operating results of Ingenios are reported in the Company’s Healthcare Innovations business segment. On March 1, 2015, the Company acquired the stock of WillCare’s Ohio operations for $3.0 million. On January 29, 2015, the Company acquired a noncontrolling interest in a development stage analytics and software company, NavHealth. The investment is an asset of the Company’s Healthcare Innovations segment. The following table summarizes the fair value estimates as of the respective acquisition dates of the assets acquired and liabilities assumed for the WillCare (final), Ingenios (final) and Black Stone (final), LTS (preliminary), Bayonne (preliminary) and Wisconsin (preliminary) acquisitions: Purchase Price Allocation Accounts receivable $ Property, plant & equipment Other assets Goodwill Other intangibles Assets acquired Liabilities assumed Net assets acquired $

QUARTERLY FINANCIAL DATA - (UNA

QUARTERLY FINANCIAL DATA - (UNAUDITED)	12 Months Ended
	Dec. 30, 2016
QUARTERLY FINANCIAL DATA - (UNAUDITED)
QUARTERLY FINANCIAL DATA - (UNAUDITED)	NOTE 12 - QUARTERLY FINANCIAL DATA— (UNAUDITED) Summarized quarterly financial data are as follows for 2016 and 2015: Dec. 30, 2016 Sep. 30, 2016 Jul. 1, 2016 Apr. 1, 2016 Jan. 1, 2016 Oct. 2, 2015 Jul. 3, 2015 Apr. 3, 2015 Net service revenues $ $ $ $ $ $ $ $ Gross margin Net income attributable to Almost Family, Inc. $ $ $ $ $ $ $ $ Average shares outstanding Basic Diluted Net income attributable to Almost Family, Inc. per share Basic $ $ $ $ $ $ $ $ Diluted $ $ $ $ $ $ $ $

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 30, 2016
Subsequent Events
Subsequent Events	NOTE 13 - SUBSEQUENT EVENTS Management has evaluated all events and transactions that occurred after December 30, 2016. The following non-recognized subsequent events were noted: CHS Home Health Acquisition On December 31, 2016, the first day of the Company’s 2017 fiscal year, the Company acquired an 80% controlling interest in the entity holding the home health and hospice assets of Community Health Systems, Inc. (NYSE: CYH) (“CHS Home Health”). With the completion of this transaction, the Company now operates 340 branches across 26 states. The purchase price of $128.0 million was funded through borrowings on the Company's Revolving Credit Facility. CHS retained the remaining 20%. Community Health Systems, Inc. ("CHS") is one of the largest publicly-traded hospital companies in the United States and a leading operator of general acute care hospitals in communities across the country. CHS Home Health, which includes the former home health and hospice operations of CHS, provides in-home outpatient care services, including skilled nursing and acute care. CHS Home Health's operations are located primarily in the Midwest and Southern United States with a major presence in Tennessee, Florida and Texas near existing CHS hospitals. The home health business consists of 74 separate home health agencies across 22 states and the hospice business consists of 15 separate hospice agencies across 7 states. The Company expects to allocate the purchase price between goodwill, intangible assets, property and equipment and working capital. Stock Transaction On January 19, 2017 subsequent to our fiscal year, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, pursuant to which the Company agreed to issue and sell to the Underwriters a total of 3,000 shares of the Company’s common stock, par value $0.10 per share (the “Common Stock”), plus an option to purchase up to 450 additional shares of Common Stock (“the Offering”), in a registered public offering pursuant to the Company’s shelf registration statement on Form S-3 (Registration No. 333-204584). On January 25, 2017, the Company sold 3,450 shares of common stock at $44.50 per share under the shelf registration statement for gross proceeds of approximately $153.5 million. Net proceeds were approximately $144.3 million, after deducting the estimated underwriting discounts and commissions and our offering expenses. Proceeds from the offering were used to repay obligations under the revolving credit facility, which increased credit available under the Facility from approximately $78.6 million at December 30, 2016 to approximately $204 million after the offering.

Summary of Accounting Policies

Summary of Accounting Policies (Policies)	12 Months Ended
	Dec. 30, 2016
Accounting Policies
Basis of Consolidation and Description Of Business	Basis of Consolidation and Description of Business The consolidated financial statements include the accounts of Almost Family, Inc. (a Delaware corporation) and its wholly-owned subsidiaries (collectively “ Almost Family ” or the “Company”). The Company is a leading provider of cost efficient, high quality home healthcare care services and related innovations to drive savings for payors and improve patient outcomes and experience.
New Accounting Pronouncements	New Accounting Pronouncements In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-15, Statement of Cash Flows, Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). ASU 2016-15 clarifies how entities should classify certain cash receipts and cash payments on the statement of cash flows. It also clarifies how the predominance principle should be applied when cash receipts and cash payments have aspects of more than one class of cash flows. ASU 2016-15 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted. The Company is currently evaluating the impact ASU 2016-15 will have on its consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation ( “ ASU 2016-09”). ASU 2016-09 is intended to simplify several aspects of the accounting for share-based payments. The guidance will be effective for fiscal years beginning after December 15, 2016, including interim periods within that year. The Company is in the process of evaluating the impact of the adoption of this ASU. In February 2016, the FASB issued ASU 2016-02, Leases ( “ ASU 2016-02”). ASU 2016-02 requires lessees to recognize assets and liabilities on their balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their income statements over the lease term. It will also require disclosures designed to give financial statement users information regarding the amount, timing, and uncertainty of cash flows arising from leases. The guidance is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted for all entities. The Company is currently evaluating the impact ASU 2016-02 will have on its consolidated financial statements and associated disclosures. In April 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (“Subtopic 835-30”): Simplifying the Presentation of Debt Issuance Costs . In certain instances, Subtopic 835-30 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. Subtopic 835-30 is effective for annual and interim periods beginning after December 15, 2015. With the adoption of Subtopic 835-30, amortization of debt issuance costs of $281 and $190 were reclassified from amortization expense to interest expense for the years-ended January 1, 2016 and December 31, 2014, respectively, while interest expense for the fiscal year ended December 30, 2016 includes $336 of debt issue costs amortization. In April 2015, the FASB issued ASU No. 2015-05, Intangibles – Goodwill and Other – Internal-Use Software (“Subtopic 350-40”): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement . Subtopic 350-40 provides guidance that all software licenses included in cloud computing arrangement be accounted for consistent with other licenses of intangible assets. However, if a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract, the accounting for which did not change. Subtopic 350-40 is effective for annual and interim periods beginning after December 15, 2015. The adoption of ASU No. 2015-05 did not affect the Company’s financial position and results of operations. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Topic 606 affects virtually all aspects of an entity’s revenue recognition, including determining the measurement of revenue and the timing of when it is recognized for the transfer of goods or services to customers. Topic 606 is effective for annual reporting periods beginning after December 15, 2017. The Company is continuing to evaluating Topic 606, but does not initially foresee a material impact from the adoption of Topic 606 on its 2018 financial position and results of operations.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. Uninsured deposits at December 30, 2016 and January 1, 2016 were approximately $7,845 and $4,681, respectively. These amounts have been deposited with national financial institutions.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives (generally two to ten years for medical and office equipment and three years for internally developed software). Leasehold improvements are depreciated over the terms of the respective leases (generally three to ten years). Such costs are periodically reviewed for recoverability when impairment indicators are present. Such indicators include, among other factors, operating losses, unused capacity, market value declines and technological obsolescence. Recorded values of asset groups of property, plant and equipment that are not expected to be recovered through undiscounted future net cash flows are written down to current fair value, which generally is determined from estimated discounted future net cash flows (assets held for use) or net realizable value (assets held for sale).
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill and indefinite lived intangible assets acquired are stated at fair value at the date of acquisition. Subsequent to acquisition, the Company conducts annual reviews for impairment, or more frequently if circumstances indicate impairment may have occurred. The Company reviews goodwill for impairment based on its identified reporting units, which are the same as its reportable segments. The Company tests goodwill for impairment by comparing the carrying value to the estimated fair value of its reporting units, determined using a combination of the market approach (guideline company and similar transaction method) and income approach (discounted cash flow analysis). The Company annually tests its indefinite-lived intangible assets, principally trade names, certificates of need, provider numbers and licenses. Specifically trade names are tested using a “relief-from-royalty” valuation method compared to the carrying value. Significant assumptions inherent in the valuation methodologies for goodwill and other intangibles are employed and include, but are not limited to, such estimates as future projected business results, growth rates, legislated changes in payment rates, weighted-average cost of capital for a market participant, royalty and discount rates . The Company has completed its most recent annual impairment tests as of December 30, 2016 and determined that no impairment existed. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives, such as the cost of non-compete agreements for which their estimated useful life is usually 3 years, beginning after the earn-out period, if any. The following table summarizes the activity related to the Company’s goodwill and other intangible assets: Other Intangible Assets Certificates of Need and Trade Non-compete Customer Goodwill Licenses Names Agreements Relationships Total Balances at December 31, 2014 $ $ $ $ $ — $ Acquisitions — Amortization — — — Balances at January 1, 2016 — Acquisitions Amortization — — Balance at December 30, 2016 $ $ $ $ $ $ In conjunction with the LTS acquisition in the Company’s HCI segment, the Company identified finite-lived intangible assets including Customer Relationships and Non-compete Agreements. Future annual amortization for these assets should approximate amortization for 2016 above. See Note 11 for further discussion of acquisitions. The following table summarizes the Company’s goodwill and other intangible assets by segment: Other Intangible Assets Certificates of Need and Trade Non-compete Customer Goodwill Licenses Names Agreements Relationships Total Visiting Nurse $ $ $ $ $ — $ Personal Care — Healthcare Innovations — — — — — January 1, 2016 balance $ $ $ $ $ — $ Visiting Nurse $ — $ Personal Care — Healthcare Innovations — December 30, 2016 balance $ $ $ $ $ $
Capitalization Policies	Capitalization Policies Maintenance, repairs and minor replacements are charged to expense as incurred. Major renovations and replacements are capitalized to appropriate property and equipment accounts. Upon sale or retirement of property, the cost and related accumulated depreciation are eliminated from the accounts and the related gain or loss is recognized in the consolidated statement of income. The Company capitalizes the cost of internally developed computer software for the Company’s own use. Software development costs of approximately $1,279, $788 and $327 were capitalized in the years ended December 30, 2016, January 1, 2016 and December 31, 2014, respectively.
Insurance Programs	Insurance Programs The Company bears significant risk under its large-deductible workers’ compensation insurance program and its self-insured employee health program. Under the workers’ compensation insurance program, the Company bears risk up to $400 per incident, after which stop-loss coverage is maintained. The Company purchases stop-loss insurance for the employee health plan that places a specific limit, generally $300, on its exposure for any individual covered life. Malpractice and general patient liability claims for incidents which may give rise to litigation have been asserted against the Company by various claimants. The claims are in various stages of processing and some may ultimately be brought to trial. The Company currently carries professional and general liability insurance coverage (on a claims made basis) for this exposure with no deductible. The Company also carries D&O coverage (also on a claims made basis) for potential claims against the Company’s directors and officers, including securities actions, with deductibles ranging from $175 to $500 per claim. The Company records estimated liabilities for its insurance programs based on information provided by the third-party plan administrators, historical claims experience, the life cycle of claims, expected costs of claims incurred but not paid, and expected costs to settle unpaid claims. The Company monitors its estimated insurance-related liabilities and recoveries, if any, on a monthly basis and records amounts due under insurance policies in other current assets, while recording the estimated carrier liability in other current liabilities. As facts change, it may become necessary to make adjustments that could be material to the Company’s results of operations and financial condition.
Accounting for Income Taxes	Accounting for Income Taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the Company’s book and tax bases of assets and liabilities and tax carry-forwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred taxes is recognized in the period in which the enactment dates change. Valuation allowances are established when necessary on a jurisdictional basis to reduce deferred tax assets to the amounts expected to be realized.
Noncontrolling Interest Redeemable	Noncontrolling Interest Redeemable The Company acquired a controlling interest in Imperium in October of 2013 and currently owns 72.0%. The Company is party to a put and call arrangement with respect to the remaining 28.0% non-controlling interest in Imperium. The redemption value for both the put and the call arrangement is equal to fair value. Due to the existing put and call arrangements, the noncontrolling interest is considered to be redeemable and is recorded on the balance sheet as a redeemable noncontrolling interest outside of permanent equity. The redeemable noncontrolling interest is recognized at the higher of 1) the accumulated earnings associated with the noncontrolling interest or 2) the redemption value as of the balance sheet date.
Seasonality	Seasonality The Company’s VN segment operations located in Florida (which generated approximately 26% of that segment’s revenues in the year ended December 30, 2016) normally experience higher admissions during the first quarter and lower admissions during the third quarter than in the other quarters due to seasonal population fluctuations.
Net Service Revenues	Net Service Revenues The Company is paid for its services primarily by federal and state third-party reimbursement programs, commercial insurance companies, and patients. Revenues are recorded at established rates in the period during which the services are rendered. Appropriate allowances to give recognition to third party payment arrangements are recorded when the services are rendered. Approximately 68% of the Company’s consolidated net service revenues are derived from the Medicare program. Net service revenues are recorded under the Medicare prospective payment program (PPS) based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) changes in the base episode payments established by the Medicare program; (b) adjustments to the base episode payments for case-mix and geographic wages; (c) a low utilization payment adjustment (LUPA) if the number of visits was fewer than five; (d) a partial payment if a patient is transferred to another provider or if a patient is received from another provider before completing the episode; (e) a payment adjustment based upon the level of therapy services required (thresholds set at 6, 14 and 20 visits); (f) an outlier payment if the patient’s care was unusually costly (capped at 10% of total reimbursement); (g) the number of episodes of care provided to a patient; and (h) a 2% reduction for sequestration. At the beginning of each Medicare episode the Company calculates an estimate of the amount of expected reimbursement based on the variables outlined above and recognizes Medicare revenue on an episode-by-episode basis during the course of each episode over its expected number of visits. Over the course of each episode, as changes in the variables become known, adjustments are calculated and recorded as needed to reflect changes in expectations for that episode from those established at the start of the 60 day period until its ultimate outcome at the end of the 60 day period is known. Substantially all remaining revenues are earned on a per visit, hour or unit basis (as opposed to episodic). For all services provided, the Company uses either payor-specific or patient-specific fee schedules for the recording of revenues at the amounts actually expected to be received. Laws and regulations governing the Medicare and Medicaid programs are extremely complex and subject to interpretation. It is common for issues to arise related to: 1) medical coding, particularly with respect to Medicare, 2) patient eligibility, particularly related to Medicaid, and 3) other reasons unrelated to credit risk, all of which may result in adjustments to recorded revenue amounts. The Company continuously evaluates the potential for revenue adjustments and when appropriate provides allowances for losses based upon the best available information. There is at least a reasonable possibility that recorded estimates could change by material amounts in the near term. Changes in estimates related to prior periods (increased) decreased revenues by approximately ($608), ($365), and ($320) in 2016, 2015 and 2014, respectively.
Revenue and Receivable Concentrations	Revenue and Receivable Concentrations The following table sets forth the percent of the Company’s revenues generated from Medicare, state Medicaid programs and other payors for the year ended: 2016 2015 2014 Medicare % % % Medicaid & other government programs: Ohio % % % Connecticut % % % New York % % — % Tennessee % % % Kentucky % % % Wisconsin % — % — % Florida % % % Others % % % Subtotal % % % All other payors % % % Total % % % Concentrations in the Company’s accounts receivable were as follows: 2016 2015 Amount Percent Amount Percent Medicare $ % $ % Medicaid & other government programs: Ohio % % Connecticut % % Tennessee % % Wisconsin % — — % Kentucky % % Florida % % New York % % Others % % Subtotal % % All other payors % % Subtotal % % Allowances Total $ $ The ability of payors to meet their obligations depends upon their financial stability, future legislation and regulatory actions. The Company does not believe there are any significant credit risks associated with receivables from Federal and state third-party reimbursement programs. The allowance for uncollectible accounts principally consists of management’s estimate of amounts that may prove uncollectible for coverage, eligibility and technical reasons.
Payor Mix Concentrations and Related Aging of Accounts Receivable	Payor Mix Concentrations and Related Aging of Accounts Receivable The approximate breakdown by payor classification as a percent of total accounts receivable, net of contractual allowances, if any, were as follows: 2016 Payor 0-90 91-180 181-365 >1 yr. Total Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % 2015 Payor 0-90 91-180 181-365 >1 yr. Total Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % Variations between years are largely attributable to acquisitions.
Allowance for Uncollectible Accounts by Payor Mix and Related Aging	Allowance for Uncollectible Accounts by Payor Mix and Related Aging The Company records an estimated allowance for uncollectible accounts by applying estimated bad debt percentages to its accounts receivable aging. The percentages to be applied by payor type are based on the Company’s historical collection and loss experience. The Company’s effective allowances for uncollectible accounts as a percent of accounts receivable were as follows: 2016 Payor 0-90 91-180 181-365 >1 yr. >2 yrs. Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % 2015 Payor 0-90 91-180 181-365 >1 yr. >2 yrs. Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % Variations between years are largely attributable to focused collection efforts for specific payors. The Company’s allowance for uncollectible accounts at December 30, 2016 and January 1, 2016 was approximately $21,302 and $17,514, respectively.
Contingent Service Revenues	Contingent Service Revenues The Company, through its Imperium acquisition, provides strategic health management services to ACOs that have been approved to participate in the Medicare Shared Savings Program (“MSSP”). In some cases, the Company also had ownership interests in ACOs beginning January 1, 2015. ACOs are entities that contract with CMS to serve the Medicare fee-for-service population with the goal of better care for individuals, improved health for populations and lower costs. ACOs share savings with CMS to the extent that the actual costs of serving assigned beneficiaries are below certain trended benchmarks of such beneficiaries and certain quality performance measures are achieved. The MSSP is relatively new and therefore has limited historical experience, which impacts the Company’s ability to accurately accumulate and interpret the data available for calculating an ACO’s shared savings, if any. MSSP payments are not recognized in revenue until persuasive evidence of an agreement exists, services have been rendered, the payment is fixed and determinable and collectability is insured, which is generally satisfied upon cash receipt. Under such agreements, the Company recognized $4.3 million and $1.4 million in MSSP payments for cash received during 2016 and 2015 related to savings generated for the program period ended December 31, 2015 and December 31, 2014, respectively, which is included in the Company’s Healthcare Innovations segment revenues. The Company has yet to recognize potential MSSP payments, if any, for savings generated for the December 31, 2016 program period.
Weighted Average Shares	Weighted Average Shares Net income per share is presented as a unit of basic shares outstanding and diluted shares outstanding. Diluted shares outstanding is computed based on the weighted average number of common shares and common equivalent shares outstanding. Common equivalent shares result from dilutive stock options and unvested restricted shares. The following table is a reconciliation of basic to diluted shares used in the earnings per share calculation for the fiscal year ended: 2016 2015 2014 Basic weighted average outstanding shares Dilutive effect of outstanding compensation awards Diluted weighted average outstanding shares The assumed conversions to common stock of 76, 20, and 94 of the Company’s outstanding stock options and unmet performance shares were excluded from the diluted EPS computation in 2016, 2015, and 2014, respectively, because these items, on an individual basis, have an anti-dilutive effect on diluted EPS.
Stock-Based Compensation	Stock-Based Compensation Stock options and restricted stock are granted under various stock compensation programs to employees and independent directors. The Company accounts for such grants in accordance with ASC Topic 718, Compensation — Stock Compensation and amortizes the fair value of awards, after estimated forfeiture, on a straight-line basis over the requisite service periods.
Accounting for Leases	Accounting for Leases The Company accounts for operating leases using the straight-line rents method, which amortizes contracted total rents due evenly over the lease term.
Advertising Costs	Advertising Costs The Company expenses the costs of advertising, as incurred. Advertising expense was $403, $393 and $306 for 2016, 2015 and 2014, respectively
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 30, 2016
Accounting Policies
Schedule of the Company's revenues generated from Medicare, state Medicaid programs and other payors	2016 2015 2014 Medicare % % % Medicaid & other government programs: Ohio % % % Connecticut % % % New York % % — % Tennessee % % % Kentucky % % % Wisconsin % — % — % Florida % % % Others % % % Subtotal % % % All other payors % % % Total % % %
Schedule of reconciliation of the weighted average shares outstanding used in the calculation of basic and diluted earnings per common share	2016 2015 2014 Basic weighted average outstanding shares Dilutive effect of outstanding compensation awards Diluted weighted average outstanding shares
Schedule of Concentrations in the Company's accounts receivable	2016 2015 Amount Percent Amount Percent Medicare $ % $ % Medicaid & other government programs: Ohio % % Connecticut % % Tennessee % % Wisconsin % — — % Kentucky % % Florida % % New York % % Others % % Subtotal % % All other payors % % Subtotal % % Allowances Total $ $
Schedule of approximate breakdown by payor classification as a percent of total accounts receivable, net of contractual allowances	2016 Payor 0-90 91-180 181-365 >1 yr. Total Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % 2015 Payor 0-90 91-180 181-365 >1 yr. Total Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % %
Schedule of the Company's effective allowances for uncollectible accounts as a percent of accounts receivable	2016 Payor 0-90 91-180 181-365 >1 yr. >2 yrs. Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % % 2015 Payor 0-90 91-180 181-365 >1 yr. >2 yrs. Medicare % % % % % Medicaid & Government % % % % % Self Pay % % % % % Insurance % % % % % Total % % % % %
Schedule of Intangible Assets and Goodwill [Table Text Block]	Other Intangible Assets Certificates of Need and Trade Non-compete Customer Goodwill Licenses Names Agreements Relationships Total Balances at December 31, 2014 $ $ $ $ $ — $ Acquisitions — Amortization — — — Balances at January 1, 2016 — Acquisitions Amortization — — Balance at December 30, 2016 $ $ $ $ $ $ Other Intangible Assets Certificates of Need and Trade Non-compete Customer Goodwill Licenses Names Agreements Relationships Total Visiting Nurse $ $ $ $ $ — $ Personal Care — Healthcare Innovations — — — — — January 1, 2016 balance $ $ $ $ $ — $ Visiting Nurse $ — $ Personal Care — Healthcare Innovations — December 30, 2016 balance $ $ $ $ $ $

ACCRUED LIABILITIES (Tables)

ACCRUED LIABILITIES (Tables)	12 Months Ended
	Dec. 30, 2016
ACCRUED LIABILITIES
Schedule of components of accrued liabilities	2016 2015 Wages and employee benefits $ $ Insurance accruals Accrued taxes Kentucky Medicaid cost report (receivable) payable Accrued professional fees and other $ $

PROPERTY AND EQUIPMENT, NET (Ta

PROPERTY AND EQUIPMENT, NET (Tables)	12 Months Ended
	Dec. 30, 2016
PROPERTY AND EQUIPMENT, NET
Schedule of Property and equipment, net	2016 2015 Leasehold improvements $ $ Medical equipment Computer equipment Internally developed software Office and other equipment Vehicles Less accumulated depreciation $ $

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 30, 2016
Income Taxes
Schedule of the components of provision for income taxes	2016 2015 2014 Federal - current $ $ $ State and local - current Deferred $ $ $
Schedule of reconciliation of the statutory to the effective rate	2016 2015 2014 Tax provision using statutory rate % % % State and local taxes, net of Federal benefit % % % Valuation allowance % % % Noncontrolling interest related % % % Permanent differences % % % Legal settlement related — % % — % Tax provision for continuing operations % % %
Schedule of the principal tax carry-forwards and temporary differences	2016 2015 Deferred tax assets Non-deductible reserves and allowances $ $ Insurance accruals Net operating loss carryforwards Valuation allowance Total deferred tax assets Deferred tax liabilities Goodwill & intangibles Accelerated depreciation Total deferred tax liabilities Net deferred tax liabilities $ $ Total net deferred tax liabilities are reflected in the accompanying balance sheet as long-term liabilities.
Schedule of changes in unrecognized tax benefits.	2016 2015 2014 Beginning of fiscal year $ $ $ — Increases related to positions taken on items from prior years — — — Decreases related to positions taken on items from prior years — — Increases related to positions taken in the current year Lapse of statute of limitations — — — Settlement of uncertain tax positions with tax authorities — — — Balance at end of fiscal year $ $ $

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
	Dec. 30, 2016
STOCKHOLDERS' EQUITY
Summary of changes in restricted share and option awards outstanding	Performance shares Restricted shares Options Wtd. Avg. Wtd. Avg. Wtd. Avg. Shares Grant Price Shares Grant Price Shares Ex. Price January 1, 2016 — — Granted Vested or Exercised — — Forfeited December 30, 2016 $ $ $
Summary of information about stock options	Options Outstanding Options Exercisable Wtd. Avg. Wtd. Avg. Range of Remaining Wtd. Avg. Remaining Wtd. Avg. Exercise Contractual Exercise Contractual Exercise Price Shares Life Price Shares Life Price $0.00-20.00 $ $ $20.01-30.00 $ $ Over $30.00 $ $ $ $
Schedule of exercisable options and related information	2016 2015 2014 Exercisable at end of year Weighted average price $ $ $ Weighted average fair value of options granted during the year $ $ $
Schedule of unvested options	Wtd. Avg. Shares Ex. Price January 1, 2016 $ Vested Granted Forfeited December 30, 2016 $
Schedule of assumptions used in determining the fair value option awards	Equivalent Expected Implied Grant date interest rate volatility expected lives March 4, 2016 % % March 2, 2015 % % March 17, 2014 % %

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 30, 2016
Commitments and Contingencies
Schedule of minimum rental payments	2017 $ 2018 2019 2020 2021 Thereafter Total $

Segment Data (Tables)

Segment Data (Tables)	12 Months Ended
	Dec. 30, 2016
Segment Data
Summary of segment data	2016 2015 2014 Net service revenues Home Health Visiting Nurse $ $ $ Personal Care Healthcare Innovations $ $ $ Operating income (loss) Home Health Visiting Nurse $ $ $ Personal Care Healthcare Innovations Unallocated $ $ $ Identifiable assets Home Health Visiting Nurse $ $ Personal Care Healthcare Innovations Unallocated $ $ Identifiable liabilities Home Health Visiting Nurse $ $ Personal Care Healthcare Innovations Unallocated $ $ Noncontrolling Interest - Redeemable Healthcare Innovations $ $ Capital expenditures Home Health Visiting Nurse $ $ $ Personal Care Healthcare Innovations — Unallocated $ $ $ Depreciation and amortization Home Health Visiting Nurse $ $ $ Personal Care Healthcare Innovations — Unallocated $ $ $

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 30, 2016
Acquisitions
Summary of estimated fair values of the assets acquired and liabilities assumed	The following table summarizes the fair value estimates as of the respective acquisition dates of the assets acquired and liabilities assumed for the WillCare (final), Ingenios (final) and Black Stone (final), LTS (preliminary), Bayonne (preliminary) and Wisconsin (preliminary) acquisitions: Purchase Price Allocation Accounts receivable $ Property, plant & equipment Other assets Goodwill Other intangibles Assets acquired Liabilities assumed Net assets acquired $

QUARTERLY FINANCIAL DATA - (U29

QUARTERLY FINANCIAL DATA - (UNAUDITED) (Tables)	12 Months Ended
	Dec. 30, 2016
QUARTERLY FINANCIAL DATA - (UNAUDITED)
Summary of quarterly financial data	Dec. 30, 2016 Sep. 30, 2016 Jul. 1, 2016 Apr. 1, 2016 Jan. 1, 2016 Oct. 2, 2015 Jul. 3, 2015 Apr. 3, 2015 Net service revenues $ $ $ $ $ $ $ $ Gross margin Net income attributable to Almost Family, Inc. $ $ $ $ $ $ $ $ Average shares outstanding Basic Diluted Net income attributable to Almost Family, Inc. per share Basic $ $ $ $ $ $ $ $ Diluted $ $ $ $ $ $ $ $

SUMMARY OF SIGNIFICANT ACCOUN30

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basis of Consolidation - (Details) $ in Thousands	Dec. 31, 2016USD ($)stateitem	Jan. 05, 2016USD ($)	Aug. 29, 2015USD ($)item	Dec. 30, 2016USD ($)item	Jan. 01, 2016USD ($)	Dec. 31, 2014USD ($)	Jul. 22, 2015state
Basis of Presentation
Number of states | state	26
Amortization of debt issuance costs | $				$ 336	$ 281	$ 190
Number of branches operated	340
Ownership percentage retained	20
Community Health Systems Inc.
Basis of Presentation
Interest acquired (as a percent)	80.00%
Number of home health branch locations operated by acquired entity	74			74
Number of hospice branch locations operated by acquired entity	15			15
Number of states	22			7
Purchase price | $	$ 128,000
LTS
Basis of Presentation
Interest acquired (as a percent)		100.00%
Purchase price | $		$ 37,000
Ingenios
Basis of Presentation
Interest acquired (as a percent)							1.00%
Number of states | state							4
Willcare
Basis of Presentation
Interest acquired (as a percent)			1.00%
Purchase price | $			$ 50,800
New York | Willcare
Basis of Presentation
Number of branches operated			12
Connecticut | Willcare
Basis of Presentation
Number of branches operated			1

SUMMARY OF SIGNIFICANT ACCOUN31

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash, Property equipment - (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016
Cash and Cash Equivalents
Uninsured deposits	$ 7,845	$ 4,681
Office and other equipment | Minimum
Cash and Cash Equivalents
Property, Plant and Equipment, Useful Life	2 years
Office and other equipment | Maximum
Cash and Cash Equivalents
Property, Plant and Equipment, Useful Life	10 years
Internally developed software
Cash and Cash Equivalents
Property, Plant and Equipment, Useful Life	3 years
Leasehold improvements | Minimum
Cash and Cash Equivalents
Property, Plant and Equipment, Useful Life	3 years
Leasehold improvements | Maximum
Cash and Cash Equivalents
Property, Plant and Equipment, Useful Life	10 years

SUMMARY OF SIGNIFICANT ACCOUN32

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Other Intangible Assets - (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Goodwill
Balance at the beginning of the period	$ 277,061
Additions	28,415	$ 84,538
Balance at the end of the period	305,476	277,061
Other Intangible Assets
Balance at the beginning of the period	64,629
Additions	21,108	10,253
Amortization	(674)	(26)
Balance at the end of the period	85,063	64,629
Goodwill and Other Intangible Assets
Goodwill	277,061	277,061	$ 192,523
Intangible Assets, Net (Excluding Goodwill)	64,629	64,629	54,402
Impairment loss on goodwill and other intangible assets	0
Visiting Nurse
Goodwill
Balance at the beginning of the period	186,384
Balance at the end of the period	193,824	186,384
Other Intangible Assets
Balance at the beginning of the period	56,182
Balance at the end of the period	60,519	56,182
Goodwill and Other Intangible Assets
Goodwill	186,384	186,384
Intangible Assets, Net (Excluding Goodwill)	56,182	56,182
Personal Care
Goodwill
Balance at the beginning of the period	72,773
Balance at the end of the period	75,003	72,773
Other Intangible Assets
Balance at the beginning of the period	8,447
Balance at the end of the period	9,444	8,447
Goodwill and Other Intangible Assets
Goodwill	72,773	72,773
Intangible Assets, Net (Excluding Goodwill)	8,447	8,447
Healthcare Innovations
Goodwill
Balance at the beginning of the period	17,904
Balance at the end of the period	36,649	17,904
Other Intangible Assets
Balance at the end of the period	15,100
Goodwill and Other Intangible Assets
Goodwill	17,904	17,904
Intangible Assets, Net (Excluding Goodwill)	$ 15,100
Non-compete Agreements
Activity related to goodwill and other intangible assets
Estimated useful life	3 years
Other Intangible Assets
Balance at the beginning of the period	$ 184
Additions	600	180
Amortization	(164)	(16)
Balance at the end of the period	620	184
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	184	184	20
Non-compete Agreements | Visiting Nurse
Other Intangible Assets
Balance at the beginning of the period	92
Balance at the end of the period	69	92
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	92	92
Non-compete Agreements | Personal Care
Other Intangible Assets
Balance at the beginning of the period	92
Balance at the end of the period	69	92
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	92	92
Non-compete Agreements | Healthcare Innovations
Other Intangible Assets
Balance at the end of the period	482
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	482
Customer Relationships
Other Intangible Assets
Additions	10,190
Amortization	(502)
Balance at the end of the period	9,688
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	9,688
Customer Relationships | Healthcare Innovations
Other Intangible Assets
Balance at the end of the period	9,688
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	9,688
Certificates of Need and Licenses
Other Intangible Assets
Balance at the beginning of the period	46,044
Additions	5,388	6,433
Balance at the end of the period	51,432	46,044
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	46,044	46,044	39,611
Certificates of Need and Licenses | Visiting Nurse
Other Intangible Assets
Balance at the beginning of the period	42,884
Balance at the end of the period	47,252	42,884
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	42,884	42,884
Certificates of Need and Licenses | Personal Care
Other Intangible Assets
Balance at the beginning of the period	3,160
Balance at the end of the period	4,180	3,160
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	3,160	3,160
Trade Names
Other Intangible Assets
Balance at the beginning of the period	18,401
Additions	4,930	3,640
Amortization	(8)	(10)
Balance at the end of the period	23,323	18,401
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	18,401	18,401	$ 14,771
Trade Names | Visiting Nurse
Other Intangible Assets
Balance at the beginning of the period	13,206
Balance at the end of the period	13,198	13,206
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	13,206	13,206
Trade Names | Personal Care
Other Intangible Assets
Balance at the beginning of the period	5,195
Balance at the end of the period	5,195	5,195
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	5,195	$ 5,195
Trade Names | Healthcare Innovations
Other Intangible Assets
Balance at the end of the period	4,930
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	$ 4,930

SUMMARY OF SIGNIFICANT ACCOUN33

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Capitalization Policies - (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Internally developed software
Capitalized software development costs
Software development costs capitalized	$ 1,279	$ 788	$ 327

SUMMARY OF SIGNIFICANT ACCOUN34

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Insurance Programs - (Details) $ in Thousands	12 Months Ended
	Dec. 30, 2016USD ($)
Large-deductible workers' compensation insurance program | Maximum
Insurance Programs
Insurance program, Company's risk per incident	$ 400
Self-insured employee health program | Maximum
Insurance Programs
Insurance program, Company's risk per individual covered life	300
Professional liability
Insurance Programs
Deductible, professional and general liability insurance coverage	0
D&O coverage | Minimum
Insurance Programs
Insurance program, Company's risk per claim	175
D&O coverage | Maximum
Insurance Programs
Insurance program, Company's risk per claim	$ 500

SUMMARY OF SIGNIFICANT ACCOUN35

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Seasonality - (Details)	Dec. 30, 2016
Visiting Nurse | Florida
Seasonality
Segment Reporting Sales Revenue Services Net Percentage	26.00%

SUMMARY OF SIGNIFICANT ACCOUN36

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Service Revenues - (Details) - Medicare program $ in Thousands	12 Months Ended
	Dec. 30, 2016USD ($)item	Jan. 01, 2016USD ($)	Dec. 31, 2014USD ($)
Net service revenues
Segment Reporting Sales Revenue Services Net Percentage	68.00%
Period of episode payment rate	60 days
Outlier payments (as a percent)	10.00%
Percentage of reduction for sequestration	2
Increase (decrease) in revenues due to changes in estimates related to prior periods | $	$ (608)	$ (365)	$ (320)
Minimum
Net service revenues
Number of therapy service visits, level one threshold	6
Number of therapy service visits, level two threshold	14
Number of therapy service visits, level three threshold	20
Maximum
Net service revenues
Number of visits for avoiding low utilization payment adjustment	5

SUMMARY OF SIGNIFICANT ACCOUN37

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue and Receivable Concentrations - (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Concentrations
Concentrations amount, gross	$ 120,514	$ 109,784
Allowances	(21,302)	(17,514)
Accounts Receivable, Net, Current, Total	$ 99,212	$ 92,270
Revenue | Revenue concentration
Concentrations
Concentrations (as a percent)	100.00%	100.00%	100.00%
Revenue | Revenue concentration | Wisconsin
Concentrations
Concentrations (as a percent)	0.90%	0.00%
Revenue | Revenue concentration | Medicare program
Concentrations
Concentrations (as a percent)	68.20%	71.40%	72.40%
Revenue | Revenue concentration | Medicaid and other government programs
Concentrations
Concentrations (as a percent)	23.20%	22.50%	19.60%
Revenue | Revenue concentration | Medicaid and other government programs | Ohio
Concentrations
Concentrations (as a percent)	9.60%	9.10%	8.80%
Revenue | Revenue concentration | Medicaid and other government programs | Connecticut
Concentrations
Concentrations (as a percent)	5.00%	5.50%	5.50%
Revenue | Revenue concentration | Medicaid and other government programs | Kentucky
Concentrations
Concentrations (as a percent)	2.30%	3.20%	2.50%
Revenue | Revenue concentration | Medicaid and other government programs | New York
Concentrations
Concentrations (as a percent)	1.00%	1.70%	1.80%
Revenue | Revenue concentration | Medicaid and other government programs | Tennessee
Concentrations
Concentrations (as a percent)	4.00%	1.70%
Revenue | Revenue concentration | Medicaid and other government programs | Florida
Concentrations
Concentrations (as a percent)	0.30%	0.90%	0.60%
Revenue | Revenue concentration | Medicaid and other government programs | Others
Concentrations
Concentrations (as a percent)	0.10%	0.40%	0.40%
Revenue | Revenue concentration | All other payors
Concentrations
Concentrations (as a percent)	8.60%	6.10%	8.00%
Accounts receivable | Receivable concentration
Concentrations
Concentrations (as a percent)	100.00%	100.00%
Accounts receivable | Receivable concentration | Medicare program
Concentrations
Concentrations (as a percent)	53.20%	45.90%
Concentrations amount, gross	$ 64,128	$ 50,369
Accounts receivable | Receivable concentration | Medicaid and other government programs
Concentrations
Concentrations (as a percent)	32.20%	26.90%
Concentrations amount, gross	$ 38,825	$ 29,478
Accounts receivable | Receivable concentration | Medicaid and other government programs | Ohio
Concentrations
Concentrations (as a percent)	9.10%	7.90%
Concentrations amount, gross	$ 10,937	$ 8,627
Accounts receivable | Receivable concentration | Medicaid and other government programs | Connecticut
Concentrations
Concentrations (as a percent)	5.60%	2.50%
Concentrations amount, gross	$ 6,735	$ 2,693
Accounts receivable | Receivable concentration | Medicaid and other government programs | Kentucky
Concentrations
Concentrations (as a percent)	3.10%	2.80%
Concentrations amount, gross	$ 3,741	$ 3,055
Accounts receivable | Receivable concentration | Medicaid and other government programs | Wisconsin
Concentrations
Concentrations (as a percent)	3.70%
Concentrations amount, gross	$ 4,451
Accounts receivable | Receivable concentration | Medicaid and other government programs | New York
Concentrations
Concentrations (as a percent)	2.70%	2.90%
Concentrations amount, gross	$ 3,216	$ 3,207
Accounts receivable | Receivable concentration | Medicaid and other government programs | Tennessee
Concentrations
Concentrations (as a percent)	4.80%	7.30%
Concentrations amount, gross	$ 5,756	$ 8,038
Accounts receivable | Receivable concentration | Medicaid and other government programs | Florida
Concentrations
Concentrations (as a percent)	2.80%	2.50%
Concentrations amount, gross	$ 3,338	$ 2,702
Accounts receivable | Receivable concentration | Medicaid and other government programs | Others
Concentrations
Concentrations (as a percent)	0.50%	1.10%
Concentrations amount, gross	$ 651	$ 1,156
Accounts receivable | Receivable concentration | All other payors
Concentrations
Concentrations (as a percent)	14.60%	27.30%
Concentrations amount, gross	$ 17,561	$ 29,937
Accounts receivable net of contractual allowances
Concentrations
Concentrations (as a percent)	100.00%	100.00%
Accounts receivable net of contractual allowances | Medicare program
Concentrations
Concentrations (as a percent)	53.00%	46.00%
Accounts receivable net of contractual allowances | Medicaid and other government programs
Concentrations
Concentrations (as a percent)	32.00%	27.00%
Accounts receivable net of contractual allowances | Self Pay
Concentrations
Concentrations (as a percent)	2.00%	9.00%
Accounts receivable net of contractual allowances | Insurance
Concentrations
Concentrations (as a percent)	13.00%	18.00%
0-90 | Accounts receivable net of contractual allowances
Concentrations
Concentrations (as a percent)	48.00%	51.00%
0-90 | Accounts receivable net of contractual allowances | Medicare program
Concentrations
Concentrations (as a percent)	27.00%	26.00%
0-90 | Accounts receivable net of contractual allowances | Medicaid and other government programs
Concentrations
Concentrations (as a percent)	15.00%	12.00%
0-90 | Accounts receivable net of contractual allowances | Self Pay
Concentrations
Concentrations (as a percent)	1.00%	6.00%
0-90 | Accounts receivable net of contractual allowances | Insurance
Concentrations
Concentrations (as a percent)	6.00%	7.00%
91-180 | Accounts receivable net of contractual allowances
Concentrations
Concentrations (as a percent)	21.00%	17.00%
91-180 | Accounts receivable net of contractual allowances | Medicare program
Concentrations
Concentrations (as a percent)	13.00%	10.00%
91-180 | Accounts receivable net of contractual allowances | Medicaid and other government programs
Concentrations
Concentrations (as a percent)	5.00%	4.00%
91-180 | Accounts receivable net of contractual allowances | Self Pay
Concentrations
Concentrations (as a percent)	0.00%	1.00%
91-180 | Accounts receivable net of contractual allowances | Insurance
Concentrations
Concentrations (as a percent)	2.00%	2.00%
181-365 | Accounts receivable net of contractual allowances
Concentrations
Concentrations (as a percent)	14.00%	21.00%
181-365 | Accounts receivable net of contractual allowances | Medicare program
Concentrations
Concentrations (as a percent)	8.00%	7.00%
181-365 | Accounts receivable net of contractual allowances | Medicaid and other government programs
Concentrations
Concentrations (as a percent)	4.00%	8.00%
181-365 | Accounts receivable net of contractual allowances | Self Pay
Concentrations
Concentrations (as a percent)	0.00%	1.00%
181-365 | Accounts receivable net of contractual allowances | Insurance
Concentrations
Concentrations (as a percent)	2.00%	5.00%
>1 yr. | Accounts receivable net of contractual allowances
Concentrations
Concentrations (as a percent)	17.00%	11.00%
>1 yr. | Accounts receivable net of contractual allowances | Medicare program
Concentrations
Concentrations (as a percent)	5.00%	3.00%
>1 yr. | Accounts receivable net of contractual allowances | Medicaid and other government programs
Concentrations
Concentrations (as a percent)	8.00%	3.00%
>1 yr. | Accounts receivable net of contractual allowances | Self Pay
Concentrations
Concentrations (as a percent)	0.00%	1.00%
>1 yr. | Accounts receivable net of contractual allowances | Insurance
Concentrations
Concentrations (as a percent)	4.00%	4.00%

SUMMARY OF SIGNIFICANT ACCOUN38

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Uncollectible Accounts by Payor Mix and Related Aging - (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2016	Sep. 30, 2016	Jul. 01, 2016	Apr. 01, 2016	Jan. 01, 2016	Oct. 02, 2015	Jul. 03, 2015	Apr. 03, 2015	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts	$ 21,302				$ 17,514				$ 21,302	$ 17,514
Sales revenue
Net service revenues	$ 153,427	$ 160,421	$ 155,996	$ 153,698	$ 145,217	$ 131,232	$ 127,366	$ 128,399	$ 623,541	$ 532,214	$ 495,829
0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									1.00%	3.00%
91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									3.00%	5.00%
181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									17.00%	38.00%
>1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									77.00%	53.00%
>2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Medicare program | 0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									1.00%	3.00%
Medicare program | 91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									3.00%	6.00%
Medicare program | 181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									16.00%	36.00%
Medicare program | >1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									73.00%	55.00%
Medicare program | >2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Medicaid and other government programs | 0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									1.00%	4.00%
Medicaid and other government programs | 91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									3.00%	5.00%
Medicaid and other government programs | 181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									16.00%	44.00%
Medicaid and other government programs | >1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									81.00%	46.00%
Medicaid and other government programs | >2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Self Pay | 0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									1.00%	4.00%
Self Pay | 91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									6.00%	3.00%
Self Pay | 181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									28.00%	34.00%
Self Pay | >1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	59.00%
Self Pay | >2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Insurance | 0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									2.00%	3.00%
Insurance | 91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									4.00%	5.00%
Insurance | 181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									20.00%	36.00%
Insurance | >1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									75.00%	56.00%
Insurance | >2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Medicare shared savings program
Sales revenue
Net service revenues									$ 4,300	$ 1,400

SUMMARY OF SIGNIFICANT ACCOUN39

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Weighted Average Shares - (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2016	Sep. 30, 2016	Jul. 01, 2016	Apr. 01, 2016	Jan. 01, 2016	Oct. 02, 2015	Jul. 03, 2015	Apr. 03, 2015	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Earnings per Common Share
Weighted Average Number of Shares Outstanding, Basic	10,162	10,172	10,158	10,089	9,775	9,604	9,393	9,353	10,153	9,505	9,333
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements									193	240	129
Weighted Average Number of Shares Outstanding, Diluted	10,330	10,310	10,322	10,260	10,000	9,822	9,569	9,521	10,346	9,745	9,462
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount									76	20	94
Advertising Costs
Advertising expense									$ 403	$ 393	$ 306

ACCRUED LIABILITIES (Details)

ACCRUED LIABILITIES (Details) - USD ($) $ in Thousands	Dec. 30, 2016	Jan. 01, 2016
ACCRUED LIABILITIES
Wages and employee benefits	$ 17,792	$ 20,687
Insurance accruals	14,535	14,541
Accrued taxes	633	643
Kentucky Medicaid cost report payable	(30)	616
Accrued professional fees and other	6,798	6,037
Total accrued liabilities	$ 39,728	$ 42,524

PROPERTY AND EQUIPMENT, NET (De

PROPERTY AND EQUIPMENT, NET (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Property and equipment
Property and equipment, gross	$ 27,809	$ 26,781
Less accumulated depreciation	(17,077)	(16,781)
Property, Plant and Equipment, Net, Total	10,732	10,000
Depreciation and amortization	3,768	3,321	$ 3,850
Leasehold improvements
Property and equipment
Property and equipment, gross	2,856	2,312
Medical equipment
Property and equipment
Property and equipment, gross	1,518	1,561
Computer equipment
Property and equipment
Property and equipment, gross	12,414	14,633
Internally developed software
Property and equipment
Property and equipment, gross	4,158	1,744
Office and other equipment
Property and equipment
Property and equipment, gross	6,717	6,369
Vehicles
Property and equipment
Property and equipment, gross	$ 146	$ 162

Revolving Credit Facility (Deta

Revolving Credit Facility (Details) - USD ($) $ in Thousands	Jan. 25, 2017	Dec. 05, 2016	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2016
Revolving credit facility
Debt issuance costs			$ 3,900	$ 1,161
Revolving credit facility	$ 78,600		262,456	$ 113,790
Transaction deposit			$ 128,930
Shares sold	3,450
Net proceeds	$ 144,300
Effective interest rate (as a percent)			3.60%	3.50%
Current facility
Revolving credit facility
Credit line		$ 225,000
Accordion feature in credit facility		$ 150,000
Debt issuance costs			$ 4,700
Current facility | LIBOR | Minimum
Revolving credit facility
Interest rate margin (as a percent)		1.50%
Current facility | LIBOR | Maximum
Revolving credit facility
Interest rate margin (as a percent)		2.75%
Community Health Systems Inc.
Revolving credit facility
Interest acquired (as a percent)					80.00%
Revolving credit facility			$ 128,900
Community Health Systems Inc. | Current facility
Revolving credit facility
Credit line					$ 350,000
Interest acquired (as a percent)					80.00%

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014	Dec. 30, 2016	Jan. 01, 2016
Operating loss carry-forwards
Uncertain tax positions	$ 2,470,000	$ 2,470,000	$ 1,186,000	$ 3,558,000	$ 2,470,000
Provision for income taxes
Federal - current	1,329,000	5,283,000	2,829,000
State and local - current	930,000	1,359,000	1,182,000
Deferred	8,725,000	3,914,000	5,500,000
Income Tax Expense (Benefit), Total	$ 10,984,000	$ 10,556,000	$ 9,511,000
Reconciliation of the statutory to the effective rate
Tax provision using statutory rate (as a percent)	35.00%	35.00%	35.00%
State and local taxes, net of Federal benefit (as a percent)	4.30%	4.40%	4.70%
Valuation allowance (as a percent)	(0.40%)	0.20%	1.00%
Noncontrolling interest related	(0.70%)	0.60%	0.40%
Permanent differences	(0.50%)	0.30%	(0.10%)
Legal settlement related	0.00%	(5.40%)
Effective Income Tax Rate Reconciliation, Percent, Total	37.70%	35.10%	41.00%
Increase in valuation allowance due to a change in expected realizability of deferred tax assets for states operating loss carry-forwards	$ 700,000
Deferred tax assets
Non-deductible reserves and allowances				12,688,000	12,855,000
Insurance accruals				3,506,000	3,431,000
Net operating loss carryforwards				5,229,000	4,550,000
Deferred tax assets, gross				21,423,000	20,836,000
Valuation allowance				(2,487,000)	(1,762,000)
Deferred tax assets				18,936,000	19,074,000
Deferred tax liabilities
Goodwill & intangibles				38,706,000	30,719,000
Accelerated depreciation				(1,375,000)	(1,449,000)
Deferred tax liabilities				(40,081,000)	(32,168,000)
Net deferred tax liabilities				(21,145,000)	(13,094,000)
Deferred tax (liabilities) assets are reflected in the accompanying balance sheet as:
Long-term liabilities				(21,145,000)	(13,094,000)
Net deferred tax liabilities				(21,145,000)	(13,094,000)
Book value of goodwill not deductible for tax purposes				105,100,000	$ 113,200,000
Changes in unrecognized tax benefits
Balance	2,470,000
Decreases related to positions taken on items from prior years	(94,000)
Increases related to positions taken in the current year	1,182,000	$ 1,284,000	$ 1,186,000
Balance	$ 3,558,000	$ 2,470,000	$ 1,186,000
State
Operating loss carry-forwards
Net operating loss carry-forwards				42,900,000
Valuation allowance				$ 35,800,000

STOCKHOLDERS' EQUITY - Employee

STOCKHOLDERS' EQUITY - Employee Stock Incentive Plans - (Details)	Mar. 04, 2016shares	Dec. 30, 2016USD ($)shares	Jan. 01, 2016USD ($)shares	Dec. 31, 2014USD ($)
Stock-based compensation
Stock-based compensation | $		$ 2,760,000	$ 2,121,000	$ 1,814,000
2000 Employee Stock Option Plan
Stock-based compensation
Shares available for future grant		0
2007 Stock and Incentive Compensation Plan
Stock-based compensation
Shares available for future grant		0
2013 Stock And Incentive Compensation Plan
Stock-based compensation
Shares available for future grant		214
Restricted shares
Stock-based compensation
Granted (in shares)		48,000
Restricted shares | 2007 Stock and Incentive Compensation Plan
Stock-based compensation
Number of shares of common stock that can be purchased		200,000
Number of anniversaries		3 years
Number of shares outstanding		162,000
Restricted shares | 2013 Stock And Incentive Compensation Plan
Stock-based compensation
Number of anniversaries		3 years
Number of shares awarded		296
Number of shares outstanding		213
Option awards
Stock-based compensation
Term of options		10 years
Vesting period		10 years
Number of shares outstanding		501,000	467,000
Option awards | 2000 Employee Stock Option Plan
Stock-based compensation
Number of shares of common stock that can be purchased		1,000,000
Term of options		10 years
Number of shares outstanding		83,000
Shares available for future grant		0
Option awards | 2007 Stock and Incentive Compensation Plan
Stock-based compensation
Number of shares of common stock that can be purchased		500,000
Term of options		10 years
Option share awards vest annually in increments (as a percent)		25.00%
Vesting period		4 years
Number of shares outstanding		230,000
Option awards | 2013 Stock And Incentive Compensation Plan
Stock-based compensation
Number of shares of common stock that can be purchased		700,000
Term of options		10 years
Option share awards vest annually in increments (as a percent)		25.00%
Vesting period		4 years
Number of shares awarded		190
Number of shares outstanding		188
Performance shares
Stock-based compensation
Granted (in shares)		56,000
Performance shares | 2013 Stock And Incentive Compensation Plan
Stock-based compensation
Vesting period	3 years
Granted (in shares)	56
Achievement percentage		100
Stock-based compensation | $		$ 0
Minimum | Performance shares | 2013 Stock And Incentive Compensation Plan
Stock-based compensation
Achievement percentage		0
Maximum | Performance shares | 2013 Stock And Incentive Compensation Plan
Stock-based compensation
Achievement percentage		200

STOCKHOLDERS' EQUITY - Changes

STOCKHOLDERS' EQUITY - Changes in award shares outstanding - (Details) - $ / shares	Mar. 04, 2016	Dec. 30, 2016
Performance shares
Change in Restricted shares
Granted (in shares)		56,000
Balance at the end of the period (in shares)		55,000
Changes in Restricted Stock, Wtd Avg Grant Price
Granted (in dollars per share)		$ 36.03
Forfeited (in dollars per share)		36.03
Balance at the end of the period (in dollars per share)		$ 36.03
Changes in option awards outstanding, Shares
Forfeited (in shares)		(1,000)
Restricted shares
Change in Restricted shares
Balance in begining of the period (in shares)		177,000
Granted (in shares)		48,000
Vested or Exercised (in shares)		(48,000)
Forfeitures (in shares)		(19,000)
Balance at the end of the period (in shares)		158,000
Changes in Restricted Stock, Wtd Avg Grant Price
Balance at the beginning of the period (in dollars per share)		$ 32.39
Granted (in dollars per share)		37.44
Vested or exercised (in dollars per share)		22.94
Forfeited (in dollars per share)		43.14
Balance at the end of the period (in dollars per share)		$ 34.93
Option awards
Change in Restricted shares
Forfeitures (in shares)		(3,000)
Changes in option awards outstanding, Shares
Balance at the beginning of the period (in shares)		467,000
Granted (in shares)		56,000
Vested or Exercised (in shares)		(19,000)
Balance at the end of the period (in shares)		501,000
Changes in option awards, Wtd Avg Ex. Price
Balance at the beginning of the period (in dollars per share)		$ 26.39
Granted (in dollars per share)		36.03
Vested or Exercised (in dollars per share)		20.85
Forfeited (in dollars per share)		(24.15)
Balance at the end of the period (in dollars per share)		$ 27.69
2000 Employee Stock Option Plan | Option awards
Changes in option awards outstanding, Shares
Balance at the end of the period (in shares)		83,000
2007 Stock and Incentive Compensation Plan | Restricted shares
Changes in option awards outstanding, Shares
Balance at the end of the period (in shares)		162,000
2007 Stock and Incentive Compensation Plan | Option awards
Changes in option awards outstanding, Shares
Balance at the end of the period (in shares)		230,000
2013 Stock And Incentive Compensation Plan | Performance shares
Change in Restricted shares
Granted (in shares)	56
2013 Stock And Incentive Compensation Plan | Restricted shares
Changes in option awards outstanding, Shares
Balance at the end of the period (in shares)		213
2013 Stock And Incentive Compensation Plan | Option awards
Changes in option awards outstanding, Shares
Balance at the end of the period (in shares)		188

STOCKHOLDERS' EQUITY - Informat

STOCKHOLDERS' EQUITY - Information about stock options - (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 04, 2016	Mar. 02, 2015	Mar. 17, 2014	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Options Outstanding
Shares				501
Wtd. Avg. Remaining Contractual Life				4 years 10 months 6 days
Wtd. Avg. Exercise Price (in dollars per share)				$ 27.69
Options Exercisable
Shares				352
Wtd. Avg. Remaining Contractual Life				3 years 5 months 23 days
Wtd. Avg. Exercise Price (in dollars per share)				$ 25.91
Assumptions used in determining the fair value option awards
Equivalent interest rate (as a percent)		2.07%	2.68%
Equivalent volatility (as a percent)		32.50%	40.00%
Dividend yield				0.00%
Dividend payouts				$ 0
Implied expected lives		6 years 10 months 10 days	8 years 3 months 26 days
Additional information
Unrecognized compensation cost				$ 5,596
Weighted-average recognition period				2 years 3 months 11 days
Range of exercise price per share from $0.00 to $20.01
Options Outstanding
Shares				93
Wtd. Avg. Remaining Contractual Life				8 months 16 days
Wtd. Avg. Exercise Price (in dollars per share)				$ 19.41
Options Exercisable
Shares				89
Wtd. Avg. Remaining Contractual Life				6 months 29 days
Wtd. Avg. Exercise Price (in dollars per share)				$ 19.41
Range of exercise price per share from $20.01 to $30.00
Options Outstanding
Shares				206
Wtd. Avg. Remaining Contractual Life				5 years 6 months 26 days
Wtd. Avg. Exercise Price (in dollars per share)				$ 22.97
Options Exercisable
Shares				159
Wtd. Avg. Remaining Contractual Life				5 years 22 days
Wtd. Avg. Exercise Price (in dollars per share)				$ 22.90
Range of exercise price per share over $30.00
Options Outstanding
Shares				202
Wtd. Avg. Remaining Contractual Life				6 years 15 days
Wtd. Avg. Exercise Price (in dollars per share)				$ 36.35
Options Exercisable
Shares				104
Wtd. Avg. Remaining Contractual Life				3 years 6 months 15 days
Wtd. Avg. Exercise Price (in dollars per share)				$ 36.13
Option awards
Exercisable Options And Related Information Abstract
Exercisable at end of year (in shares)				352	312	273
Weighted average price (in dollars per share)				$ 25.91	$ 25.49	$ 25.59
Weighted average fair value of options granted during the year (in dollars per share)				$ 18.80	$ 12.35	$ 11.61
Changes in unvested options, Shares
Balance at the beginning of the period (in shares)				155,000
Vested (in shares)				61,000
Granted (in shares)				56,000
Forfeited (in shares)				(1,000)
Balance at the end of the period (in shares)				149,000	155,000
Changes in unvested options, Wtd Avg Ex. Price
Balance at the beginning of the period (in dollars per share)				$ 28.20
Vested (in dollars per share)				26.25
Granted (in dollars per share)				36.03
Forfeited (in dollars per share)				(36.03)
Balance at the end of the period (in dollars per share)				$ 31.91	$ 28.20
Term of options				10 years
Assumptions used in determining the fair value option awards
Equivalent interest rate (as a percent)	1.68%
Equivalent volatility (as a percent)	49.00%
Implied expected lives	8 years 4 months 6 days
Additional information
Total fair value of option shares vested				$ 697	$ 487

STOCKHOLDERS' EQUITY - Employ47

STOCKHOLDERS' EQUITY - Employee Stock Purchase and Directors Deferred Compensation Plan - (Details) - Employee stock purchase plan shares in Thousands	Dec. 30, 2016shares
Employee Stock Purchase Plan
Number of shares of common stock authorized for issuance	300
Number of shares of common stock available	300

RETIREMENT PLAN (Details)

RETIREMENT PLAN (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
RETIREMENT PLAN
Employer matching contribution (as a percent)	0.25%
Voluntary contribution by participating employee (as a percent)	5.00%
Requisite service period for eligibility of employer matching contribution	1 year
Retirement plan expense	$ 1,054	$ 1,080	$ 910

Commitments and Contingencies49

Commitments and Contingencies (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Operating Leases, Rent Expense	$ 13,969	$ 11,356	$ 12,846
Minimum rental payments
2,017	9,317
2,018	6,802
2,019	4,530
2,020	3,636
2,021	2,713
Thereafter	7,085
Total	$ 34,083
Suncrest | Receivable concentration
Minimum rental payments
Concentration Risk, Percentage	1.00%

SEGMENT DATA (Details)

SEGMENT DATA (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2016USD ($)	Sep. 30, 2016USD ($)	Jul. 01, 2016USD ($)	Apr. 01, 2016USD ($)	Jan. 01, 2016USD ($)	Oct. 02, 2015USD ($)	Jul. 03, 2015USD ($)	Apr. 03, 2015USD ($)	Dec. 30, 2016USD ($)segmentdivision	Jan. 01, 2016USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Segment data
Net service revenues	$ 153,427	$ 160,421	$ 155,996	$ 153,698	$ 145,217	$ 131,232	$ 127,366	$ 128,399	$ 623,541	$ 532,214	$ 495,829
Operating income									34,932	32,384	24,667
Identifiable assets	658,712				464,769				658,712	464,769
Identifiable liabilities	354,532				190,869				354,532	190,869
Noncontrolling Interest - Redeemable	2,256				3,639				2,256	3,639	3,639	$ 3,639
Capital expenditures									6,206	3,117	1,231
Depreciation and amortization									$ 4,445	3,927	3,913
Number of divisions | division									2
Number of reportable segments | segment									2
Corporate expenses.
Segment data
Operating income									$ (40,808)	(30,441)	(30,672)
Identifiable assets	25,627				20,904				25,627	20,904
Identifiable liabilities	292,423				133,349				292,423	133,349
Capital expenditures									3,905	1,418	617
Depreciation and amortization									1,820	2,356	2,392
Visiting Nurse
Segment data
Net service revenues									436,147	401,051	380,788
Operating income before corporate expenses									56,574	49,872	42,899
Identifiable assets	456,841				310,317				456,841	310,317
Identifiable liabilities	31,792				31,570				31,792	31,570
Capital expenditures									1,099	1,388	465
Depreciation and amortization									1,124	1,210	1,250
Personal Care
Segment data
Net service revenues									161,367	127,712	112,497
Operating income before corporate expenses									13,509	14,170	12,453
Identifiable assets	116,085				111,524				116,085	111,524
Identifiable liabilities	25,241				24,425				25,241	24,425
Capital expenditures									294	203	149
Depreciation and amortization									301	264	271
Healthcare Innovations
Segment data
Net service revenues									26,027	3,451	2,544
Operating income before corporate expenses									5,657	(1,217)	(13)
Identifiable assets	60,159				22,024				60,159	22,024
Identifiable liabilities	5,076				1,525				5,076	1,525
Noncontrolling Interest - Redeemable	$ 2,256				$ 3,639				2,256	3,639	$ 3,639
Capital expenditures									908	108
Depreciation and amortization									$ 1,200	97
Medicare program
Segment data
Segment revenues (as a percent)	68.00%								68.00%
Medicare program | Visiting Nurse
Segment data
Segment revenues (as a percent)	95.00%								95.00%
Medicaid and other government programs | Personal Care
Segment data
Segment revenues (as a percent)	83.00%								83.00%
Medicare shared savings program
Segment data
Net service revenues									$ 4,300	$ 1,400

Acquisitions (Details)

Acquisitions (Details)

Jun. 18, 2016USD ($)

Jan. 05, 2016USD ($)item

Nov. 05, 2015USD ($)

Aug. 29, 2015USD ($)location

Jul. 22, 2015USD ($)state

Mar. 01, 2015USD ($)

Dec. 30, 2016USD ($)

Jan. 01, 2016USD ($)

Jan. 01, 2016USD ($)

Dec. 31, 2014USD ($)

Dec. 31, 2016state

Sep. 30, 2016

Jul. 01, 2016

Acquisitions

Period over which goodwill and other intangible assets are expected to be deductible for tax purposes

15 years

Stock Issued During Period Value Acquisitions

$ 10,675,000

$ 18,982,000

Cash paid

31,486,000

$ 82,578,000

$ 969,000

Number of States | state

26

Approximate fair value estimates of the assets acquired and liabilities assumed

Goodwill

305,476,000

$ 277,061,000

$ 277,061,000

$ 192,523,000

Ingenios

Acquisitions

Interest acquired (as a percent)

1.00%

Stock Issued During Period Value Acquisitions

$ 11,400,000

Cash paid

$ 2,000,000

Number of States | state

4

Willcare

Acquisitions

Interest acquired (as a percent)

1.00%

Purchase price

$ 50,800,000

Black Stone

Acquisitions

Purchase price

$ 40,000,000

LTS

Acquisitions

Interest acquired (as a percent)

100.00%

Purchase price

$ 37,000,000

Accounts receivable

0

Approximate fair value estimates of the assets acquired and liabilities assumed

Accounts receivable

$ 0

The Wisconsin acquisition

Acquisitions

Purchase price

$ 6,100,000

WillCare, Ingenios, Black Stone), LTS, Bayonne and Wisconsin

Acquisitions

Accounts receivable

13,478,000

Approximate fair value estimates of the assets acquired and liabilities assumed

Accounts receivable

13,478,000

Property, plant & equipment

2,947,000

Other assets

2,072,000

Goodwill

112,953,000

Other intangibles

31,460,000

Assets acquired

162,910,000

Liabilities assumed

(9,844,000)

Net assets acquired

$ 153,066,000

Ohio | Willcare

Acquisitions

Purchase price

$ 3,000,000

Connecticut | Willcare

Acquisitions

Number of visiting nurse and personal care branch locations | location

1

New York | WillCare

Acquisitions

Number of visiting nurse and personal care branch locations | location

12

Healthcare Innovations

Acquisitions

Interest acquired (as a percent)

72.00%

61.50%

Revenue concentration | LTS

Acquisitions

Concentrations (as a percent)

74.40%

Number of customers | item

2

QUARTERLY FINANCIAL DATA - (U52

QUARTERLY FINANCIAL DATA - (UNAUDITED) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2016	Sep. 30, 2016	Jul. 01, 2016	Apr. 01, 2016	Jan. 01, 2016	Oct. 02, 2015	Jul. 03, 2015	Apr. 03, 2015	Dec. 30, 2016	Jan. 01, 2016	Jan. 01, 2016	Dec. 31, 2014
QUARTERLY FINANCIAL DATA - (UNAUDITED)
Net service revenues	$ 153,427	$ 160,421	$ 155,996	$ 153,698	$ 145,217	$ 131,232	$ 127,366	$ 128,399	$ 623,541		$ 532,214	$ 495,829
Gross margin	69,952	74,347	72,304	71,466	67,521	61,757	61,023	60,072	288,069		250,372	231,835
Income from continuing operations attributable to Almost Family, Inc.									17,653	$ 20,009	20,009	13,763
Net income attributable to Almost Family, Inc.	$ 3,592	$ 5,366	$ 4,777	$ 3,917	$ 2,806	$ 7,799	$ 5,010	$ 4,394	$ 18,172		$ 19,541	$ 13,524
Average shares outstanding
Basic (in shares)	10,162	10,172	10,158	10,089	9,775	9,604	9,393	9,353	10,153		9,505	9,333
Diluted (in shares)	10,330	10,310	10,322	10,260	10,000	9,822	9,569	9,521	10,346		9,745	9,462
Net income attributable to Almost Family, Inc. per share
Basic (in dollars per share)	$ 0.35	$ 0.53	$ 0.47	$ 0.39	$ 0.29	$ 0.81	$ 0.53	$ 0.47	$ 1.74		$ 2.11	$ 1.47
Diluted (in dollars per share)	$ 0.35	$ 0.52	$ 0.46	$ 0.38	$ 0.28	$ 0.79	$ 0.52	$ 0.46	$ 1.71		$ 2.05	$ 1.45

Subsequent Events (Details)

Subsequent Events (Details) $ / shares in Units, $ in Thousands	Jan. 25, 2017USD ($)$ / sharesshares	Jan. 19, 2017$ / sharesshares	Dec. 31, 2016USD ($)statelocationitem	Dec. 30, 2016USD ($)item	Jan. 26, 2017USD ($)	Jan. 01, 2016USD ($)
Subsequent Events
Number of states | state			26
Number of branches operated | item			340
Ownership percentage retained			20
Revolving credit facility	$ 78,600			$ 262,456		$ 113,790
Subsequent event
Subsequent Events
Number of states | state			26
Number of branches operated | location			340
Common stock issued (in shares) | shares	3,450	3,000
Price per share sold | $ / shares	$ 44.50	$ 0.10
Number of additional shares available in registered public offering | shares		450
Gross proceeds	$ 153,500
Net proceeds	$ 144,300
Revolving credit facility					$ 204,000
Community Health Systems Inc.
Subsequent Events
Interest acquired (as a percent)			80.00%
Number of home health branch locations operated by acquired entity | item			74	74
Number of hospice branch locations operated by acquired entity | item			15	15
Number of states			22	7
Purchase price			$ 128,000
Revolving credit facility				$ 128,900
Community Health Systems Inc. | Subsequent event
Subsequent Events
Interest acquired (as a percent)			80.00%
Purchase price			$ 128,000
Ownership percentage retained			20

SCHEDULE II - VALUATION AND QUA

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2016	Jan. 01, 2016	Dec. 31, 2014
Allowance for uncollectible accounts:
Balance at Beginning of Period	$ 17,514		$ 15,586
Additions/(Deductions) Charged to Costs and Expenses	11,708	$ 12,743	9,413
Additions/(Deductions) Charged to Other Accounts	25	1,891
Deductions	(7,945)	(6,000)	(16,119)
Balance at End of Period	$ 21,302	$ 17,514	$ 8,880